Package | hl7.terminology.r4b |
Type | CodeSystem |
Id | v3-NullFlavor |
FHIR Version | R4B |
Source | http://terminology.hl7.org/http://terminology.hl7.org/6.0.2/CodeSystem-v3-NullFlavor.html |
URL | http://terminology.hl7.org/CodeSystem/v3-NullFlavor |
Version | 3.0.0 |
Status | active |
Date | 2019-03-20 |
Name | NullFlavor |
Title | NullFlavor |
Realm | uv |
Authority | hl7 |
Description | A collection of codes specifying why a valid value is not present. |
Copyright | This material derives from the HL7 Terminology THO. THO is copyright ©1989+ Health Level Seven International and is made available under the CC0 designation. For more licensing information see: https://terminology.hl7.org/license.html |
Content | complete |
CodeSystem | |
null-flavor-cs | Null Flavor translations |
translationNullFlavor | Übersetzung NullFlavor |
ConceptMap | |
CertifierTypesCM | CertifierTypes Concept Map |
ContributoryTobaccoUseCM | ContributoryTobaccoUse Concept Map |
DeathPregnancyStatusCM | PregnancyStatus Concept Map |
MethodOfDispositionCM | MethodOfDisposition Concept Map |
PlaceOfDeathCM | PlaceOfDeath Concept Map |
PlaceOfInjuryCM | PlaceOfInjury Concept Map |
SpouseAliveCM | SpouseAlive Concept Map |
TransportationIncidentRoleCM | TransportationIncidentRole Concept Map |
maritalstatus-ech11-to-fhir | MaritalStatus eCH-011 to FHIR mapping |
ConceptMapBirthAttendantTitlesVitalRecords | BirthAttendantTitles Concept Map |
ConceptMapBirthSexChildVitalRecords | BirthSex Concept Map |
ConceptMapBirthSexFetusVitalRecords | BirthSex Concept Map |
ConceptMapEducationLevelVitalRecords | EducationLevel Concept Map |
ConceptMapHispanicNoUnknownVitalRecords | HispanicNoUnknown Concept Map |
ConceptMapMaritalStatusVitalRecords | MaritalStatus Concept Map |
ConceptMapRaceMissingValueReasonVitalRecords | RaceMissingValueReason Concept Map |
ConceptMapUnitsOfAgeVitalRecords | UnitsOfAge Concept Map |
ConceptMapYesNoNotApplicableVitalRecords | NotApplicable Concept Map |
ConceptMapYesNoUnknownNotApplicableVitalRecords | YesNoUnknownNotApplicable Concept Map |
ConceptMapYesNoUnknownVitalRecords | YesNoUnknown Concept Map |
ConceptMap-statoCivile | Mapping fra VS HL7 e Tabella ISTAT Stato Civile |
CF-NullFlavorDataAbsentReason | C-CDA NullFlavor to FHIR Data Absent Reason |
FC-DataAbsentReasonNullFlavor | FHIR Data Absent Reason to C-CDA NullFlavor |
FC-ProcedureStatus | FHIR to C-CDA Procedure Status |
ConceptMap-language | NZ Central Region Language Concept Map |
ConceptMap-marital-status | NZ Central Region Marital Status Concept Map |
table-hl70002-to-v3-maritalstatus | Table HL70002 to V3 MaritalStatus Map |
BirthAttendantTitlesCM | BirthAttendantTitles Concept Map |
BirthDeliveryOccurredCM | BirthDeliveryOccurred Concept Map |
FetalDeathCauseOrConditionCM | FetalDeathCauseOrCondition Concept Map |
FetalDeathTimePointsCM | FetalDeathTimePoints Concept Map |
FetalPresentationCM | FetalPresentation Concept Map |
KBV_CM_Base_Terminology_Complete_German | KBV_CM_Base_Terminology_Complete_German |
AllergieCategorieCodelijst-to-AllergyIntoleranceCategory | AllergieCategorieCodelijst to AllergyIntoleranceCategory |
ContactTypeCodeLijst-to-ActEncounterCode | ContactTypeCodeLijst to ActEncounterCode |
GeslachtCodelijst-to-AdministrativeGender | GeslachtCodelijst to AdministrativeGender |
NaamgebruikCodelijst-to-HumanNameAssemblyOrder | NaamgebruikCodelijst to HumanNameAssemblyOrder |
VerificatieStatusCodelijst-to-ConditionVerificationStatus | VerificatieStatusCodelijst to ConditionVerificationStatus |
BeCivilstate-to-MaritalStatus | BeCivilstate_to_MaritalStatus |
NameUsage-to-HumanNameAssemblyOrder | NameUsage_to_HumanNameAssemblyOrder |
CategorieCodelijst-to-AllergyIntoleranceCategory | CategorieCodelijst to AllergyIntoleranceCategory |
ConceptMap-statoCivile | Mapping fra VS HL7 e Tabella ISTAT Stato Civile |
ValueSet | |
VRM-CertAvailable-vs | Certificate Available Values |
VRM-PregnancyOutcomes-vs | Pregnancy Outcome Values |
birthsex | Birth Sex |
CDANullFlavor | CDANullFlavor |
marital-status-vs | Marital status translations |
vrdr-activity-at-time-of-death-vs | Activity at Time of Death ValueSet |
vrdr-certifier-types-vs | Certifier Types Value Set |
vrdr-contributory-tobacco-use-vs | Contributory Tobacco Use ValueSet |
vrdr-death-pregnancy-status-vs | Death Pregnancy Status ValueSet |
vrdr-method-of-disposition-vs | Method of Disposition ValueSet |
vrdr-place-of-death-vs | Place of Death ValueSet |
vrdr-place-of-injury-vs | Place of Injury ValueSet |
vrdr-spouse-alive-vs | Spouse Alive ValueSet |
vrdr-transportation-incident-role-vs | Transportation Incident Role ValueSet |
ValueSet-birth-attendant-titles-vr | Value Set - Birth Attendants Titles Vital Records |
ValueSet-education-level-vr | Value Set - Education Level Vital Records |
ValueSet-marital-status-vr | Value Set - Marital Status Vital Records |
ValueSet-race-missing-value-reason-vr | Value Set - Race Missing Value Reason Vital Records |
ValueSet-sex-assigned-at-birth-vr | Value Set - Sex Assigned At Birth Vital Records |
ValueSet-units-of-age-vr | Value Set - Units of Age Vital Records |
ValueSet-yes-no-not-applicable-vr | Value Set - Yes No Not Applicable Vital Records |
ValueSet-yes-no-unknown-not-applicable-vr | Value Set - Yes No Unknown NotApplicable Vital Records |
ValueSet-yes-no-unknown-vr | Value Set - Yes No Unknown Vital Records |
mcode-radiotherapy-modality-vs | Radiotherapy Modality Value Set |
mcode-radiotherapy-technique-vs | Radiotherapy Technique Value Set |
be-civilstate | BeCivilState |
be-vs-vaccination-administration-route | BeVSVaccineAdministrationRoute |
PrimaryCarerParentGrandparent | Primary Carer Of Parent Or Grandparent |
vs-affectedOrgan-eu-i4rc | Affected Organs (surgery) |
istat-provincia | ISTAT - Province |
statoCivile | Stato Civile |
statoEsenzione | Stato Esenzione |
gender-identity | Gender Identity |
v3-AskedButUnknown | AskedButUnknown |
v3-ClassNullFlavor | ClassNullFlavor |
v3-NoInformation | NoInformation |
v3-NullFlavor | NullFlavor |
v3-Other | Other |
v3-Unknown | Unknown |
yes-no-unknown-not-applicable | Yes No Unknown NotApplicable |
AxillaSurgeryVS | Axilla surgery ValueSet |
BreastSurgeryTypeVS | Types of breast surgery ValueSet |
ChemoTherapyTypeVS | Type of chemotherapy ValueSet |
ComplicationImpactVS | Impact of complication ValueSet |
ComplicationTypeVS | Type of complication ValueSet |
EstrogenStatusVS | Estrogen receptor status ValueSet |
GermlineMutationVS | Germline Mutation ValueSet |
GradingVS | Grading of tumor ValueSet |
HistologicalTypeVS | Histological type of the tumor ValueSet |
HormonalTherapyTypeVS | Type of hormonal therapy ValueSet |
InvolvedMarginsReoperationTypeVS | Re-operation due to involved margins ValueSet |
LocationRadiotherapyVS | The location of radiotherapy ValueSet |
MenopausalStatusVS | Menopausal status of patient ValueSet |
PatientTreatPrefVS | Patient treatment preference ValueSet |
ProgesteroneStatusVS | Progesterone receptor status ValueSet |
ReconstructionTypeVS | Type of reconstruction surgery ValueSet |
RecurrenceMethodVS | Recurrence method ValueSet |
RecurrenceVS | Recurrence of neoplasm ValueSet |
RelationshipStatusVS | Relationship status of patient ValueSet |
ReoperationReasonVS | Reasoncode of the re-operation |
ReoperationTypeVS | Type of re-operation |
SACQPatientComorbidityHistory | SACQ Patient's comorbidity history ValueSet |
TNMDistantMetastasesVS | TNM Distant Metastases ValueSet |
TNMPrimaryTumorVS | TNM Primary Tumor ValueSet |
TNMRegionalNodesVS | TNM Regional Nodes ValueSet |
TargetedAxillaSurgeryVS | Targeted axilla surgery ValueSet |
TargetedTherapyVS | Type of targeted therapy ValueSet |
TherapyIntentVS | Intent of therapy ValueSet |
TreatmentPlanNotFollowedVS | Treatment Plan Not Followed ValueSet |
TreatmentTypeVS | Type of treatments ValueSet |
us-ph-pregnancy-status | US Public Health Pregnancy Status |
medcom-core-PractitionerRoles | MedComCorePractitionerRoles |
IHE.PCC.mPSC.DataAbsentReason.VS | IHE PCC mPSC Data Absent Reason Value Set |
SDOHCC-ValueSetObservationMethod | SDOHCC ValueSet Observation Method |
SDOHCC-ValueSetPronounsValue | SDOHCC ValueSet Pronouns Value |
ValueSet-allergy-reaction | NZ Central Region - Allergy Reaction Value Set |
ValueSet-flag-alert-code | NZ Central Region - Flag Alert Code Value Set |
ValueSet-hospital-code | NZ Central Region - Hospital Value Set |
ValueSet-language | NZ Central Region - Language Value Set |
ValueSet-marital-status | NZ Central Region - Marital Status Value Set |
DocReason | CRD Coverage Information Documentation Reason Value Set |
informationNeeded | CRD Information Needed Value Set |
be-civilstate | BeCivilState |
loinc-pregnancy-intent-code | LOINC + HL7 NullFlavor妊娠計畫值集 |
snomed-pregnancy-status-code | SNOMED CT + HL7 NullFlavor妊娠狀態值集 |
snomed-sexual-orientation-code | SNOMED CT + HL7 NullFlavor 性傾向值集 |
us-ph-valueset-pregnancy-status | US Public Health VaueSet - Pregnancy Status |
ValueSet-birth-attendant-titles | Birth Attendants Titles |
ValueSet-birth-delivery-occurred | Birth Delivery Occurred |
ValueSet-fetal-death-cause-or-condition | Fetal Death Cause or Condition |
ValueSet-fetal-death-time-points | Fetal Death Time Points |
ValueSet-fetal-presentations | Fetal Presentations |
ValueSet-fetal-remains-disposition-method | Fetal Remains Disposition Method |
ValueSet-infections-during-pregnancy-live-birth | Infections During Pregnancy Live Birth |
ValueSet-newborn-congenital-anomalies | Newborn Congenital Anomalies |
AxillaSurgeryVS | Axilla surgery ValueSet |
BreastSurgeryTypeVS | Types of breast surgery ValueSet |
ChemoTherapyTypeVS | Type of chemotherapy ValueSet |
ComplicationImpactVS | Impact of complication ValueSet |
ComplicationTypeVS | Type of complication ValueSet |
EstrogenStatusVS | Estrogen receptor status ValueSet |
GermlineMutationVS | Germline Mutation ValueSet |
GradingVS | Grading of tumor ValueSet |
HistologicalTypeVS | Histological type of the tumor ValueSet |
HormonalTherapyTypeVS | Type of hormonal therapy ValueSet |
InvolvedMarginsReoperationTypeVS | Re-operation due to involved margins ValueSet |
LocationRadiotherapyVS | The location of radiotherapy ValueSet |
MenopausalStatusVS | Menopausal status of patient ValueSet |
PatientTreatPrefVS | Patient treatment preference ValueSet |
ProgesteroneStatusVS | Progesterone receptor status ValueSet |
ReconstructionTypeVS | Type of reconstruction surgery ValueSet |
RecurrenceMethodVS | Recurrence method ValueSet |
RecurrenceVS | Recurrence of neoplasm ValueSet |
RelationshipStatusVS | Relationship status of patient ValueSet |
ReoperationReasonVS | Reasoncode of the re-operation |
ReoperationTypeVS | Type of re-operation |
SACQPatientComorbidityHistory | SACQ Patient's comorbidity history ValueSet |
TNMDistantMetastasesVS | TNM Distant Metastases ValueSet |
TNMPrimaryTumorVS | TNM Primary Tumor ValueSet |
TNMRegionalNodesVS | TNM Regional Nodes ValueSet |
TargetedAxillaSurgeryVS | Targeted axilla surgery ValueSet |
TargetedTherapyVS | Type of targeted therapy ValueSet |
TherapyIntentVS | Intent of therapy ValueSet |
TreatmentPlanNotFollowedVS | Treatment Plan Not Followed ValueSet |
TreatmentTypeVS | Type of treatments ValueSet |
us-core-documentreference-type | US Core DocumentReference Type |
ValueSet-yes-no-not-applicable | ValueSet - Yes No NotApplicable |
name-assembly-order | HumanNameAssemblyOrder |
fmc-sexual-orientation-vs | Fresenius Sexual Orientation Value Set |
NICE-AdministrationRoute | NICE-AdministrationRoute |
NICE-AdmitSource | NICE-AdmitSource |
NICE-ContactType | NICE-ContactType |
NICE-DischargeDisposition | NICE-DischargeDisposition |
NICE-TreatmentCodelist | NICE-TreatmentCodelist |
MedikationsplanPlusPregnancystatus | MedikationsplanPlusVSPregnancystatus |
answerSetAcuteHBVD | Anwort akute Infektion aufgrund wessen bei Hepatitis B |
answerSetAcuteHCVD | Anwort akute Infektion aufgrund wessen bei Hepatitis C |
answerSetBeforeOrAfter1991 | Anwort Vor oder nach 1991 |
answerSetCauseDiagnosisMYTD | Anwort Anlass der Diagnose bei Tuberkulose |
answerSetCoinfectionHDVD | Anwort Koinfektion mit Hepatitis B bei Hepatitis D |
answerSetConservationCLOD | Antwort zur Art der Lebensmittelkonservierung bei Botulismus |
answerSetConsumptionCLOD | Antwort zum Ort des Verzehrs bei Botulismus |
answerSetCountry | Anwort Country mit staatenlos und Ausland |
answerSetDiagnosisCJKD | Antwortmöglichkeiten für die Angabe der Ausprägung des Meldetatbestands "Creutzfeldt-Jakob-Krankheit (CJK)" |
answerSetFoodCLOD | Antwort zum verzehrten Lebensmittel bei Botulismus |
answerSetFormBAND | Antwortmöglichkeiten für die Angabe der Ausprägung des Meldetatbestands "Milzbrand" |
answerSetFormCDFD | Antwortmöglichkeiten für die Angabe der Ausprägung des Meldetatbestands "Clostridioides-difficile-Erkrankung, schwere Verlaufsform" |
answerSetFormCJKD | Antwortmöglichkeiten für die Angabe der Ausprägung des Meldetatbestands "Creutzfeldt-Jakob-Krankheit (CJK)" |
answerSetFormCLOD | Antwortmöglichkeiten für die Angabe der Ausprägung des Meldetatbestands "Botulismus" |
answerSetFormCORD | Antwortmöglichkeiten für die Angabe der Ausprägung des Meldetatbestands "Diphtherie" |
answerSetFormMYBD | Antwortmöglichkeiten für die Angabe der Ausprägung des Meldetatbestands "Tuberkulose, bei Behandlungsabbruch" |
answerSetFormYPSD | Antwortmöglichkeiten für die Angabe der Ausprägung des Meldetatbestands "Pest" |
answerSetGeographicRegion | Antwort geographische Region |
answerSetHospitalizationReason | Antwort Grund der Hospitalisierung |
answerSetInfectionAnimalWhereHUSD | Anwort Tierkontakt wo bei Hämolytisch-urämisches Syndrom (HUS) |
answerSetInfectionEnvironmentSettingCVDD | Antwortmöglichkeiten zur Angabe des Infektionsumfelds bei dem Meldetatbestand "Coronavirus-Krankheit-2019 (COVID-19)" |
answerSetInfectionEnvironmentSettingMYTD | Antwortmöglichkeiten zur Angabe des Infektionsumfelds bei dem Meldetatbestand "Tuberkulose" |
answerSetInfectionPathCJKD | Antwortmöglichkeiten zur Angabe des Infektionswegs bei dem Meldetatbestand "Creutzfeldt-Jakob-Krankheit (CJK)" |
answerSetInfectionPathHAVD | Antwortmöglichkeiten zur Angabe des Infektionswegs bei dem Meldetatbestand "Hepatitis A" |
answerSetInfectionPathHBVD | Antwortmöglichkeiten zur Angabe des Infektionswegs bei dem Meldetatbestand "Hepatitis B" |
answerSetInfectionPathHCVD | Antwortmöglichkeiten zur Angabe des Infektionswegs bei dem Meldetatbestand "Hepatitis C" |
answerSetInfectionPathHEVD | Antwortmöglichkeiten zur Angabe des Infektionswegs bei dem Meldetatbestand "Hepatitis E" |
answerSetInfectionPathHUSD | Antwortmöglichkeiten zur Angabe des Infektionswegs bei dem Meldetatbestand "Hämolytisch-urämisches Syndrom (HUS)" |
answerSetInfectionPathIZVD | Antwortmöglichkeiten zur Angabe des Infektionswegs bei dem Meldetatbestand "Zoonotische Influenza" |
answerSetInfectionPathMPXD | Antwortmöglichkeiten zur Angabe des Infektionswegs bei dem Meldetatbestand "Mpox" |
answerSetInfectionPathOPXD | Antwortmöglichkeiten zur Angabe des Infektionswegs bei dem Meldetatbestand "Orthopocken, andere" |
answerSetInfectionPathWhoHUSD | Antwortmöglichkeiten zur Angabe der Person, bei der sich infiziert wurde, bei dem Meldetatbestand "Hämolytisch-urämisches Syndrom (HUS)" |
answerSetInfectionRiskAnimalHEVD | Antwort zu Tierkontakt bei Hepatitis E |
answerSetInfectionRiskAnimalHUSD | Antwort zu Tierkontakt bei Hämolytisch-urämisches Syndrom (HUS) |
answerSetInfectionRiskAnimalRBVD | Antwort zu Tierkontakt bei Tollwut |
answerSetInfectionRiskAnimalTTVD | Antwort zu Tierkontakt bei Tollwutexpositionsverdacht |
answerSetInfectionRiskCVDD | Antwortmöglichkeiten für die Angabe der Risikofaktoren in Zusammenhang mit dem Meldetatbestand "Coronavirus-Krankheit-2019 (COVID-19)" |
answerSetInfectionRiskIZVD | Antwortmöglichkeiten für die Angabe der Risikofaktoren in Zusammenhang mit dem Meldetatbestand "Zoonotische Influenza" |
answerSetInfectionRiskJobHEVD | Antwortmöglichkeiten für die Angabe der beruflichen Risiken in Zusammenhang mit dem Meldetatbestand "Hepatitis E" |
answerSetInfectionRiskJobHTVD | Antwortmöglichkeiten für die Angabe der beruflichen Risiken in Zusammenhang mit dem Meldetatbestand "Hantavirus-Erkrankung, hämorrhagischer Verlauf" |
answerSetInfectionRiskNEID | Antwortmöglichkeiten für die Angabe der Risikofaktoren in Zusammenhang mit dem Meldetatbestand "Meningokokken, invasive Erkrankung" |
answerSetInfectionRiskOtherHEVD | Antwort zu Sonstiger Kontakt bei Hepatitis E |
answerSetLocationLymphNodeSwellingMPXD | Anwort Lokalisation der Lymphknotenschwellung bei Mpox |
answerSetLocationMucosalLesionsMPXD | Anwort Lokalisation der Schleimhautläsionen bei Mpox |
answerSetLocationSkinLesionsMPXD | Anwort Lokalisation der Hautläsionen bei Mpox |
answerSetMajorSiteMYTD | Anwort hauptsächlich betroffenes Organ bei Tuberkulose |
answerSetManufacturingCLOD | Antwort zur Art der Lebensmittelherstellung bei Botulismus |
answerSetMethodCDFD | Antwortmöglichkeiten für die Angabe der Nachweismethode der Clostridioides-difficile-Erkrankung, schwere Verlaufsform |
answerSetMilitaryAffiliation | Antwort Zugehörigkeit zur Bundeswehr |
answerSetMinorSiteMYTD | Anwort weiteres betroffenes Organ bei Tuberkulose |
answerSetPathogenHFAD | Antwortmöglichkeiten zur Angabe des Erregers bei dem Meldetatbestand "Hämorrhagisches Fieber" |
answerSetPregnancyWeek | Anwort Schwangerschaftswoche |
answerSetResultOfPrevTreatmentMYTD | Anwort Ergebnis der Vorbehandlung bei Tuberkulose |
answerSetResultOfTreatmentMYTD | Anwort Behandlungsergebnis bei Tuberkulose |
answerSetStadiumHBVD | Anwort Stadium der Infektion bei Hepatitis B |
answerSetStadiumHCVD | Anwort Stadium der Infektion bei Hepatitis C |
answerSetTransmissionKindHBVD | Antwortmöglichkeiten für nosokomiale Übertragung bei Hepatitis B |
answerSetTransmissionKindHCVD | Antwortmöglichkeiten für nosokomiale Übertragung bei Hepatitis C |
answerSetTrimester | Antwort zum Trimester |
nullFlavor | NullFlavor |
vaccineBAND | Antwortmöglichkeiten für die Angabe des Impfstoffs in Bezug auf den Meldetatbestand "Milzbrand" |
vaccineBPSD | Antwortmöglichkeiten für die Angabe des Impfstoffs in Bezug auf den Meldetatbestand "Keuchhusten" |
vaccineCDFD | Antwortmöglichkeiten für die Angabe des Impfstoffs in Bezug auf den Meldetatbestand "Clostridioides-difficile-Erkrankung, schwere Verlaufsform" |
vaccineCORD | Antwortmöglichkeiten für die Angabe des Impfstoffs in Bezug auf den Meldetatbestand "Diphtherie" |
vaccineDEND | Antwortmöglichkeiten für die Angabe des Impfstoffs in Bezug auf den Meldetatbestand "Denguefieber" |
vaccineEBVD | Antwortmöglichkeiten für die Angabe des Impfstoffs in Bezug auf den Meldetatbestand "Ebolafieber" |
vaccineGFVD | Antwortmöglichkeiten für die Angabe des Impfstoffs in Bezug auf den Meldetatbestand "Gelbfieber" |
vaccineHAVD | Antwortmöglichkeiten für die Angabe des Impfstoffs in Bezug auf den Meldetatbestand "Hepatitis A" |
vaccineHBVD | Antwortmöglichkeiten für die Angabe des Impfstoffs in Bezug auf den Meldetatbestand "Hepatitis B" |
vaccineHDVD | Antwortmöglichkeiten für die Angabe des Impfstoffs in Bezug auf den Meldetatbestand "Hepatitis D" |
vaccineHEVD | Antwortmöglichkeiten für die Angabe des Impfstoffs in Bezug auf den Meldetatbestand "Hepatitis E" |
vaccineHXXD | Antwortmöglichkeiten für die Angabe des Impfstoffs in Bezug auf den Meldetatbestand "Akute Virushepatitis" |
vaccineIZVD | Antwortmöglichkeiten für die Angabe des Impfstoffs in Bezug auf den Meldetatbestand "Zoonotische Influenza" |
vaccineMPVD | Antwortmöglichkeiten für die Angabe des Impfstoffs in Bezug auf den Meldetatbestand "Mumps" |
vaccineMPXD | Antwortmöglichkeiten für die Angabe des Impfstoffs in Bezug auf den Meldetatbestand "Mpox" |
vaccineMSVD | Antwortmöglichkeiten für die Angabe des Impfstoffs in Bezug auf den Meldetatbestand "Masern" |
vaccineMYTD | Antwortmöglichkeiten für die Angabe des Impfstoffs in Bezug auf den Meldetatbestand "Tuberkulose" |
vaccineNEID | Antwortmöglichkeiten für die Angabe des Impfstoffs in Bezug auf den Meldetatbestand "Meningokokken, invasive Erkrankung" |
vaccinePKVD | Antwortmöglichkeiten für die Angabe des Impfstoffs in Bezug auf den Meldetatbestand "Pocken" |
vaccinePOVD | Antwortmöglichkeiten für die Angabe des Impfstoffs in Bezug auf den Meldetatbestand "Poliomyelitis" |
vaccineRBVD | Antwortmöglichkeiten für die Angabe des Impfstoffs in Bezug auf den Meldetatbestand "Tollwut" |
vaccineRUVD | Antwortmöglichkeiten für die Angabe des Impfstoffs in Bezug auf den Meldetatbestand "Röteln, postnatal" |
vaccineSSPD | Antwortmöglichkeiten für die Angabe des Impfstoffs in Bezug auf den Meldetatbestand "Subakute sklerosierende Panenzephalitis (SSPE)" |
vaccineSTYD | Antwortmöglichkeiten für die Angabe des Impfstoffs in Bezug auf den Meldetatbestand "Typhus" |
vaccineSXXD | Antwortmöglichkeiten für die Angabe des Impfstoffs in Bezug auf den Meldetatbestand "Paratyphus/Typhus, nicht differenziert" |
vaccineTTVD | Antwortmöglichkeiten für die Angabe des Impfstoffs in Bezug auf den Meldetatbestand "Tollwutexpositionsverdacht" |
vaccineVCHD | Antwortmöglichkeiten für die Angabe des Impfstoffs in Bezug auf den Meldetatbestand "Cholera" |
vaccineVZWD | Antwortmöglichkeiten für die Angabe des Impfstoffs in Bezug auf den Meldetatbestand "Windpocken" |
vaccineVZZD | Antwortmöglichkeiten für die Angabe des Impfstoffs in Bezug auf den Meldetatbestand "Herpes Zoster" |
yesOrNoOrNoInformation | Anwort Ja/Nein/nicht erhoben/nicht ermittelbar |
legal-status | Legal Status |
personal-income-source | Personal Income Source |
pre-existing-conditions | Pre-existing Conditions |
official-language | Preferred Official Language |
service-termination-reason | Service Termination Reason |
human-language | Language |
bornInCanadaResponse | Born in Canada Response |
employment-status | Employment Status |
highest-level-of-education-attained | Highest Level of Education Attained |
sexual-orientation | Sexual Orientation |
total-household-income | Total Household Income |
versicherungsart-de-basis | VersicherungsartDeBasisVS |
no-colonoscopy-boston-bowel-preparation-scale | Colonoscopy Report Boston Bowel Preparation Scale |
no-colonoscopy-complication | Colonoscopy Report Complications |
no-colonoscopy-complication-consequence | Colonoscopy Report Complication Consequences |
no-colonoscopy-current-medication | Colonoscopy Report Current Medication |
no-colonoscopy-followup | Colonoscopy Report Follow Up |
no-colonoscopy-laxatives | Colonoscopy Report Laxatives |
no-colonoscopy-laxatives-split-dose | Colonoscopy Report Laxatives Split Dose |
no-colonoscopy-medication | Colonoscopy Report Medication |
no-colonoscopy-medication-krg | KRG Medication |
no-colonoscopy-method-tissue-removal-biopsy | Colonoscopy Report Tissue Removal Method |
no-colonoscopy-paris-polyp-classification | Colonoscopy Report Colonoscopy Paris Polyp Classification |
no-colonoscopy-procedure-reason-krg | KRG Indication |
no-colonoscopy-relevant-conditions | Colonoscopy Report Relevant Conditions |
no-colonoscopy-procedure-reason-gastronet | Colonoscopy Report Indication |
HealthcareServiceSpecialty | Fachspezialisierung (Werteliste) |
PractitionerRole | Personenrolle (Werteliste) |
birthsex | Birth Sex |
answerSetAddressUse | Antwortenmöglichkeiten Adressnutzung |
ValueSet-yes-no-unknown-not-applicable | ValueSet - Yes No Unknown NotApplicable |
gambling-activities-in-last-year | Gambling Activities In Last Year |
religion-and-spiritual-affiliation | ReligionAndSpiritualAffiliation |
israel-hmo | Israeli Health Management Organization (קופת חולים) |
indigenousidentitycode | Indigenous Identity Code |
genderidentityvaluecode | Gender Identity Value Set |
genderusedvaluecode | Gender Used Value Set |
recordedgender | Recorded Gender Value Set |
sexassignedatbirth | Sex assigned at Birth |
sexualorientationcode | Sex Orientation Value Set |
2.16.840.1.113883.2.4.3.11.60.40.2.7.3.2--20200901000000 | AlcoholGebruikStatusCodelijst |
2.16.840.1.113883.2.4.3.11.60.40.2.8.3.2--20200901000000 | AlertNaamCodelijst |
2.16.840.1.113883.2.4.3.11.60.40.2.8.2.2--20200901000000 | AllergieCategorieCodelijst |
2.16.840.1.113883.2.4.3.11.60.40.2.15.1.3--20200901000000 | BestemmingCodelijst |
2.16.840.1.113883.2.4.3.11.60.40.2.12.8.6--20200901000000 | ConditiesTijdensMetingCodelijst |
2.16.840.1.113883.2.4.3.11.60.40.2.15.1.1--20200901000000 | ContactTypeCodelijst |
2.16.840.1.113883.2.4.3.11.60.40.2.7.4.2--20200901000000 | DrugsGebruikStatusCodelijst |
2.16.840.1.113883.2.4.3.11.60.40.2.7.4.1--20200901000000 | DrugsOfGeneesmiddelSoortCodelijst |
2.16.840.1.113883.2.4.3.11.60.40.2.12.8.1--20200901000000 | GCS_EyesCodelijst |
2.16.840.1.113883.2.4.3.11.60.40.2.12.8.2--20200901000000 | GCS_MotorCodelijst |
2.16.840.1.113883.2.4.3.11.60.40.2.12.8.8--20200901000000 | GCS_MotorCodelijstBaby |
2.16.840.1.113883.2.4.3.11.60.40.2.12.8.7--20200901000000 | GCS_MotorCodelijstKleuter |
2.16.840.1.113883.2.4.3.11.60.40.2.12.8.3--20200901000000 | GCS_VerbalCodelijst |
2.16.840.1.113883.2.4.3.11.60.40.2.12.8.5--20200901000000 | GCS_VerbalCodelijstBaby |
2.16.840.1.113883.2.4.3.11.60.40.2.12.8.4--20200901000000 | GCS_VerbalCodelijstKleuter |
2.16.840.1.113883.2.4.3.11.60.40.2.0.1.1--20200901000000 | GeslachtCodelijst |
2.16.840.1.113883.2.4.3.11.60.40.2.17.1.8--20200901000000 | GeslachtCodelijst |
2.16.840.1.113883.2.4.3.11.60.40.2.15.1.2--20200901000000 | HerkomstCodelijst |
2.16.840.1.113883.2.4.3.11.60.40.2.7.5.1--20200901000000 | LevensovertuigingCodelijst |
2.16.840.1.113883.2.4.3.11.60.40.2.20.4.1--20200901000000 | NaamgebruikCodelijst |
2.16.840.1.113883.2.4.3.11.60.121.11.12--20200901000000 | ProductCodeCodelijsten |
2.16.840.1.113883.2.4.3.11.60.40.2.10.1.1--20200901000000 | ProductTypeCodelijst |
2.16.840.1.113883.2.4.3.11.60.40.2.3.1.1--20200901000000 | RelatieCodelijst |
2.16.840.1.113883.2.4.3.11.60.40.2.19.3.1--20200901000000 | SoortAandoeningCodelijst |
2.16.840.1.113883.2.4.3.11.60.40.2.7.2.3--20200901000000 | SoortTabakGebruikCodelijst |
2.16.840.1.113883.2.4.3.11.60.40.2.5.2.1--20200901000000 | StomaTypeCodelijst |
2.16.840.1.113883.2.4.3.11.60.40.2.8.2.5--20200901000000 | SymptoomCodelijst |
2.16.840.1.113883.2.4.3.11.60.40.2.7.2.2--20200901000000 | TabakGebruikStatusCodelijst |
2.16.840.1.113883.2.4.3.11.60.40.2.7.4.3--20200901000000 | ToedieningswegCodelijst |
2.16.840.1.113883.2.4.3.11.60.40.2.5.1.4--20200901000000 | VerificatieStatusCodelijst |
2.16.840.1.113883.2.4.3.11.60.40.2.12.19.4--20200901000000 | VisusMeetHulpmiddelCodelijst |
2.16.840.1.113883.2.4.3.11.60.40.2.12.19.3--20200901000000 | VisusMetingKaartCodelijst |
2.16.840.1.113883.2.4.3.11.60.40.2.12.19.2--20200901000000 | VisusMetingTypeCodelijst |
2.16.840.1.113883.2.4.3.11.60.40.2.7.15.1--20200901000000 | WilsverklaringTypeCodelijst |
2.16.840.1.113883.2.4.3.11.60.40.2.19.2.5--20200901000000 | WondRandCodelijst |
2.16.840.1.113883.2.4.3.11.60.40.2.19.2.4--20200901000000 | WondSoortCodelijst |
2.16.840.1.113883.2.4.3.11.60.40.2.7.8.1--20200901000000 | WoningTypeCodelijst |
2.16.840.1.113883.2.4.3.11.60.40.2.4.16.2--20200901000000 | ZienHulpmiddelTypeCodelijst |
2.16.840.1.113883.2.4.3.11.60.40.2.17.1.5--20200901000000 | ZorgverlenerRolCodelijst |
Salutation | Anrede |
vs-orpha-predisposition-eu-pcsp | Hereditary Predispositions (Orphacode) |
vs-othUnkTxt-eu-pcsp | Other/Unknown/Text |
vs-unknownOther-eu-pcsp | Unknown|Other |
cyehr-vs-ehdsinullflavor | Cyprus EHR Value Set: eHDSI Null Flavor |
cyehr-vs-drugormedicationtype | Cyprus EHR Value Set: Drug Or Medication Type |
cyehr-vs-drugusestatus | Cyprus EHR Value Set: Drug Use Status |
cyehr-vs-exercise | Cyprus EHR Value Set: Exercise |
cyehr-vs-findingrelatedtosleep | Cyprus EHR Value Set: Finding Related To Sleep |
cyehr-vs-respiratoryrhythm | Cyprus EHR Value Set: Respiratory Rhythm |
cyehr-vs-tobaccotype | Cyprus EHR Value Set: Tobacco Type |
cyehr-vs-heartrhythm | Cyprus EHR Value Set: Heart Rhythm |
fr-core-vs-marital-status | FR Core ValueSet Patient gender INS ValueSet |
gender-identity | Gender Identity |
v3-AskedButUnknown | AskedButUnknown |
v3-ClassNullFlavor | ClassNullFlavor |
v3-NoInformation | NoInformation |
v3-NullFlavor | NullFlavor |
v3-Other | Other |
v3-Unknown | Unknown |
2.16.840.1.114222.4.11.1006 | Type of Long Term Care Facility |
2.16.840.1.114222.4.11.1010 | Microscopic Exam Culture Site (TB) |
2.16.840.1.114222.4.11.1018 | Non Paint Lead Source |
2.16.840.1.114222.4.11.1021 | Number Of Lesions (VZ) |
2.16.840.1.114222.4.11.1022 | Occupation Risk Category (TB) |
2.16.840.1.114222.4.11.1026 | Pregnancy Trimester |
2.16.840.1.114222.4.11.1032 | Rash Distribution (VZ) |
2.16.840.1.114222.4.11.1033 | Rash Location First Noted (VZ) |
2.16.840.1.114222.4.11.1035 | Reason Therapy Stopped (TB) |
2.16.840.1.114222.4.11.1048 | Strain Type (VZ) |
2.16.840.1.114222.4.11.1050 | Batch Deactivation Reason |
2.16.840.1.114222.4.11.1051 | Substance Treatment Refusal Reason |
2.16.840.1.114222.4.11.1052 | Transmission Setting (NND) |
2.16.840.1.114222.4.11.1056 | Vaccination Location (CRA) |
2.16.840.1.114222.4.11.1058 | Vaccine Purchased With Funds |
2.16.840.1.114222.4.11.1060 | Abnormal Chest X-ray Condition Status |
2.16.840.1.114222.4.11.3015 | Ethnicity Group including Unknown |
2.16.840.1.114222.4.11.3017 | Lab Test Result (PHLIP Flu) |
2.16.840.1.114222.4.11.3024 | Blood Contact Frequency (Hepatitis) |
2.16.840.1.114222.4.11.3025 | Case Confirmation Method |
2.16.840.1.114222.4.11.3026 | Case Detection Method |
2.16.840.1.114222.4.11.3027 | Case Transmission Mode |
2.16.840.1.114222.4.11.3030 | Disease Acquired Jurisdiction |
2.16.840.1.114222.4.11.3033 | Number Of Sex Partners (Hepatitis) |
2.16.840.1.114222.4.11.3035 | Reason For Test (Hepatitis) |
2.16.840.1.114222.4.11.3036 | Reporting Source Type |
2.16.840.1.114222.4.11.3037 | Tattoo Obtained From (Hepatitis) |
2.16.840.1.114222.4.11.3040 | Isolate Not Available EIP Test Reason |
2.16.840.1.114222.4.11.3041 | Isolate Not Received Reason |
2.16.840.1.114222.4.11.3042 | Isolate Not Sent To NARMS Reason |
2.16.840.1.114222.4.11.3046 | Specimen Reshipment Reason |
2.16.840.1.114222.4.11.3048 | Lab Test Interpretation |
2.16.840.1.114222.4.11.3059 | Clinical Syndrome (Arbovirus) |
2.16.840.1.114222.4.11.3061 | Public Private Lab |
2.16.840.1.114222.4.11.3064 | Yes No Unknown No Answer |
2.16.840.1.114222.4.11.3067 | Virus Variant Type (Animal Rabies) |
2.16.840.1.114222.4.11.3068 | Animal Species (Animal Rabies) |
2.16.840.1.114222.4.11.3069 | Yes No Unknown Not Done |
2.16.840.1.114222.4.11.3070 | Botulism Food Source Type (FDD) |
2.16.840.1.114222.4.11.3071 | Pregnancy Outcome (FDD) |
2.16.840.1.114222.4.11.3072 | Animal Type (FDD) |
2.16.840.1.114222.4.11.3073 | Botulinum Toxin Type (FDD) |
2.16.840.1.114222.4.11.3074 | Case Traced to Carrier |
2.16.840.1.114222.4.11.3075 | Cholera Risk Factor (FDD) |
2.16.840.1.114222.4.11.3076 | Cholera Sequelae (FDD) |
2.16.840.1.114222.4.11.3077 | Cholera Signs Symptoms (FDD) |
2.16.840.1.114222.4.11.3078 | Cyclosporiasis Signs Symptoms (FDD) |
2.16.840.1.114222.4.11.3081 | Fetal Neonatal Infection Type (FDD) |
2.16.840.1.114222.4.11.3082 | Fetal Neonatal Specimen Type |
2.16.840.1.114222.4.11.3083 | Food Cooking Method (FDD) |
2.16.840.1.114222.4.11.3084 | Food Processing Method (FDD) |
2.16.840.1.114222.4.11.3085 | Fresh Berries (FDD) |
2.16.840.1.114222.4.11.3086 | Fresh Herbs (FDD) |
2.16.840.1.114222.4.11.3087 | Fresh Produce (FDD) |
2.16.840.1.114222.4.11.3088 | Information Source |
2.16.840.1.114222.4.11.3090 | Lettuce Type (FDD) |
2.16.840.1.114222.4.11.3091 | Maternal Infection (FDD) |
2.16.840.1.114222.4.11.3092 | Meat Purchase Info (FDD) |
2.16.840.1.114222.4.11.3093 | Non Pork Type (FDD) |
2.16.840.1.114222.4.11.3094 | Other Related Cases |
2.16.840.1.114222.4.11.3095 | Outbreak Type (FDD) |
2.16.840.1.114222.4.11.3096 | Pork Type (FDD) |
2.16.840.1.114222.4.11.3097 | Present Absent Unknown Not Examined |
2.16.840.1.114222.4.11.3098 | Recreational Water (FDD) |
2.16.840.1.114222.4.11.3099 | Seafood Purchase Info (FDD) |
2.16.840.1.114222.4.11.3101 | Skin Exposure (FDD) |
2.16.840.1.114222.4.11.3102 | Skin Exposure Activity (FDD) |
2.16.840.1.114222.4.11.3103 | Suspected Food Consumed (FDD) |
2.16.840.1.114222.4.11.3104 | Swimming Pool Type (FDD) |
2.16.840.1.114222.4.11.3105 | Tap Water Source (FDD) |
2.16.840.1.114222.4.11.3108 | Travel Purpose |
2.16.840.1.114222.4.11.3109 | Travelers Health Info Source |
2.16.840.1.114222.4.11.3110 | Trichinellosis Signs Symptoms (FDD) |
2.16.840.1.114222.4.11.3111 | Typhoid Signs Symptoms (FDD) |
2.16.840.1.114222.4.11.3112 | Underlying Conditions |
2.16.840.1.114222.4.11.3113 | Water Salinity (FDD) |
2.16.840.1.114222.4.11.3114 | Well Water Treatment (FDD) |
2.16.840.1.114222.4.11.3115 | Wound History |
2.16.840.1.114222.4.11.3117 | Body Site (FDD) |
2.16.840.1.114222.4.11.3119 | Acute Convalescent IgG Difference (VPD) |
2.16.840.1.114222.4.11.3120 | Antibiotic Received (Pertussis) |
2.16.840.1.114222.4.11.3121 | Birth Attendees (VPD) |
2.16.840.1.114222.4.11.3122 | Birth Location (VPD) |
2.16.840.1.114222.4.11.3123 | Birth Outcome (VPD) |
2.16.840.1.114222.4.11.3125 | Case Classification Exposure Source |
2.16.840.1.114222.4.11.3126 | Genotype (Measles) |
2.16.840.1.114222.4.11.3127 | Genotype (Rubella) |
2.16.840.1.114222.4.11.3128 | Immunization Information Source (CRS) |
2.16.840.1.114222.4.11.3129 | Injury Occurred Environment (VPD) |
2.16.840.1.114222.4.11.3130 | Injury Type (VPD) |
2.16.840.1.114222.4.11.3134 | No Case Reason (CRS) |
2.16.840.1.114222.4.11.3137 | Prenatal Care Provider (Rubella) |
2.16.840.1.114222.4.11.3138 | Relationship (VPD) |
2.16.840.1.114222.4.11.3140 | Specimen Source (CRS) |
2.16.840.1.114222.4.11.3141 | Specimen Source (VPD) |
2.16.840.1.114222.4.11.3142 | Test Method EIA IgM |
2.16.840.1.114222.4.11.3143 | Tetanus Type (VPD) |
2.16.840.1.114222.4.11.3144 | Treatment Outcome Tetanus (VPD) |
2.16.840.1.114222.4.11.3145 | Vaccine Doses Received (Pertussis) |
2.16.840.1.114222.4.11.3146 | Vaccine Doses Received (Tetanus) |
2.16.840.1.114222.4.11.3147 | Medication Received (VZ) |
2.16.840.1.114222.4.11.3148 | PCR Specimen Source (VZ) |
2.16.840.1.114222.4.11.3150 | IgM Test Type (VZ) |
2.16.840.1.114222.4.11.3151 | IgG Test Type (VZ) |
2.16.840.1.114222.4.11.3154 | Vaccines Administered (VZ) |
2.16.840.1.114222.4.11.3159 | Reporting Lab Type |
2.16.840.1.114222.4.11.3161 | Primary Reason For Evaluation (TB) |
2.16.840.1.114222.4.11.3162 | Risk Factors (TB) |
2.16.840.1.114222.4.11.3163 | Immigration Status |
2.16.840.1.114222.4.11.3164 | Sputum Culture Conversion Not Documented Reason |
2.16.840.1.114222.4.11.3166 | Cause of Death Related to TB |
2.16.840.1.114222.4.11.3167 | Therapy Extended Reason (TB) |
2.16.840.1.114222.4.11.3169 | Birth Country (TB) |
2.16.840.1.114222.4.11.3200 | Birth Country |
2.16.840.1.114222.4.11.3201 | Geographical location history |
2.16.840.1.114222.4.11.3244 | Medication Treatment (Flu) |
2.16.840.1.114222.4.11.3246 | Specimen (Flu) |
2.16.840.1.114222.4.11.3254 | Employment Status (Flu) |
2.16.840.1.114222.4.11.3259 | Age Group (Flu) |
2.16.840.1.114222.4.11.3261 | Death Location (Flu) |
2.16.840.1.114222.4.11.3264 | Sterile Specimen (Pediatric Flu) |
2.16.840.1.114222.4.11.3265 | Positive Negative Unknown |
2.16.840.1.114222.4.11.3266 | Microorganism (Pediatric Flu) |
2.16.840.1.114222.4.11.3267 | Non-Sterile Specimen (Pediatric Flu) |
2.16.840.1.114222.4.11.3268 | Acute Illness Complications (Pediatric Flu) |
2.16.840.1.114222.4.11.3269 | Underlying Conditions (Pediatric Flu) |
2.16.840.1.114222.4.11.3301 | Lab Test Interpretation (VPD) |
2.16.840.1.114222.4.11.3302 | Lab Test Procedure (Measles) |
2.16.840.1.114222.4.11.3303 | Specimen Source (Measles) |
2.16.840.1.114222.4.11.3304 | Parotitis Laterality (Mumps) |
2.16.840.1.114222.4.11.3305 | Type of Deafness (Mumps) |
2.16.840.1.114222.4.11.3306 | Lab Test Procedure (Mumps) |
2.16.840.1.114222.4.11.3307 | Specimen Source (Mumps) |
2.16.840.1.114222.4.11.3308 | Complications (Malaria) |
2.16.840.1.114222.4.11.3310 | Medication Missed (Malaria) |
2.16.840.1.114222.4.11.3311 | Medication Prophylaxis (Malaria) |
2.16.840.1.114222.4.11.3312 | Medication Treatment (Malaria) |
2.16.840.1.114222.4.11.3313 | Species (Malaria) |
2.16.840.1.114222.4.11.3314 | Specimen Type (Malaria) |
2.16.840.1.114222.4.11.3315 | Travel Reason (Malaria) |
2.16.840.1.114222.4.11.3316 | Antimicrobial Agent (IPD) |
2.16.840.1.114222.4.11.3318 | Bacterial Infection Syndrome (IPD) |
2.16.840.1.114222.4.11.3319 | Oxacillin Interpretation (IPD) |
2.16.840.1.114222.4.11.3320 | Serotype Method (IPD) |
2.16.840.1.114222.4.11.3321 | Sterile Specimen (IPD) |
2.16.840.1.114222.4.11.3322 | Underlying Conditions (IPD) |
2.16.840.1.114222.4.11.3323 | Birth Outcome (Rubella) |
2.16.840.1.114222.4.11.3336 | Susceptibility Result (IPD) |
2.16.840.1.114222.4.11.3402 | Age Unit (Syndromic Surveillance) |
2.16.840.1.114222.4.11.3405 | Race Category including Unknown |
2.16.840.1.114222.4.11.3406 | Disease Acquired Jurisdiction (NETSS) |
2.16.840.1.114222.4.11.3407 | Case Class Status (NETSS) |
2.16.840.1.114222.4.11.3408 | Age Unit (NETSS) |
2.16.840.1.114222.4.11.3409 | Transmission Setting (NETSS) |
2.16.840.1.114222.4.11.3410 | Vaccine Not Given Reasons (NETSS) |
2.16.840.1.114222.4.11.3412 | Injury Occurred Environment (NETSS) |
2.16.840.1.114222.4.11.3413 | Injury Type (NETSS) |
2.16.840.1.114222.4.11.3414 | Birth Attendees (NETSS) |
2.16.840.1.114222.4.11.3415 | Vaccines Administered (NETSS) |
2.16.840.1.114222.4.11.3416 | Manufacturers Of Vaccines (NETSS) |
2.16.840.1.114222.4.11.3417 | Contact Type Hepatitis A (NETSS) |
2.16.840.1.114222.4.11.3418 | Sexual Preference (NETSS) |
2.16.840.1.114222.4.11.3419 | Lab Test Result Lyme (NETSS) |
2.16.840.1.114222.4.11.3420 | Microorganism (NETSS) |
2.16.840.1.114222.4.11.3421 | Bacterial Infection Syndrome (NETSS) |
2.16.840.1.114222.4.11.3422 | Associated Conditions (NETSS) |
2.16.840.1.114222.4.11.3423 | Antibiotic Treatment (NETSS) |
2.16.840.1.114222.4.11.3425 | Geographic Region (NETSS) |
2.16.840.1.114222.4.11.3432 | Serogroup (NETSS) |
2.16.840.1.114222.4.11.3435 | Serotype (NETSS) |
2.16.840.1.114222.4.11.3598 | Wound Depth Tetanus (NETSS) |
2.16.840.1.114222.4.11.3599 | Time Period Tetanus (NETSS) |
2.16.840.1.114222.4.11.3600 | Stay Period Hepatitis (NETSS) |
2.16.840.1.114222.4.11.4005 | Lab Result (Babesiosis) |
2.16.840.1.114222.4.11.6001 | Certifier Types (NCHS) |
2.16.840.1.114222.4.11.6003 | Pregnancy Status (NCHS) |
2.16.840.1.114222.4.11.6004 | Contributory Tobacco Use (NCHS) |
2.16.840.1.114222.4.11.6005 | Transportation Relationships (NCHS) |
2.16.840.1.114222.4.11.6070 | Infections During Pregnancy - Live Birth (NCHS) |
2.16.840.1.114222.4.11.7103 | VPD Laboratory Coded Observation |
2.16.840.1.114222.4.11.7104 | VPD Specimen Type |
2.16.840.1.114222.4.11.7111 | Birth Attendant Titles (NCHS) |
2.16.840.1.114222.4.11.7112 | Fetal Death Time Points (NCHS) |
2.16.840.1.114222.4.11.7113 | Fetal Presentations (NCHS) |
2.16.840.1.114222.4.11.7124 | Birth or Delivery Occurred (NCHS) |
2.16.840.1.114222.4.11.7135 | Infections During Pregnancy Fetal Death (NCHS) |
2.16.840.1.114222.4.11.7166 | Binational Reporting Criteria (BIDS) |
2.16.840.1.114222.4.11.7167 | Case Transmission Mode (BIDS) |
2.16.840.1.114222.4.11.7170 | Specimen Site (BIDS) |
2.16.840.1.114222.4.11.7171 | Salmonella Serogroup (BIDS) |
2.16.840.1.114222.4.11.7174 | Campylobacter Nonculture Test Type (BIDS) |
2.16.840.1.114222.4.11.7176 | STEC Nonculture Test Type (BIDS) |
2.16.840.1.114222.4.11.7177 | E. coli Shiga Toxin Test Type (BIDS) |
2.16.840.1.114222.4.11.7178 | E. coli Shiga Toxin (BIDS) |
2.16.840.1.114222.4.11.7179 | Vibrio Culture Species (BIDS) |
2.16.840.1.114222.4.11.7180 | Vibrio Serotype (BIDS) |
2.16.840.1.114222.4.11.7181 | Vibrio Biotype (BIDS) |
2.16.840.1.114222.4.11.7182 | Vibrio Cholera Toxin Test Type (BIDS) |
2.16.840.1.114222.4.11.7188 | Travel Reason (Hepatitis A) |
2.16.840.1.114222.4.11.7189 | Specimen Source (STD) |
2.16.840.1.114222.4.11.7191 | Syphilis Neurologic Involvement (STD) |
2.16.840.1.114222.4.11.7192 | HIV Status (STD) |
2.16.840.1.114222.4.11.7193 | YNRD (CDC) |
2.16.840.1.114222.4.11.7195 | Clinician Observed Lesions (STD) |
2.16.840.1.114222.4.11.7199 | Detection Method (STD) |
2.16.840.1.114222.4.11.7203 | Quantitative Syphilis Test Result (STD) |
2.16.840.1.114222.4.11.7204 | Race Category including Refused |
2.16.840.1.114222.4.11.7205 | Race Category including Null Flavor |
2.16.840.1.114222.4.11.7206 | Lab Test Result Qualitative (NND) |
2.16.840.1.114222.4.11.7212 | Certifier Titles (NCHS) |
2.16.840.1.114222.4.11.7216 | Place of Death (NCHS) |
2.16.840.1.114222.4.11.7217 | Lab Test Reactivity (NND) |
2.16.840.1.114222.4.11.7218 | Syphilis Clinical Stage (CS) |
2.16.840.1.114222.4.11.7219 | Syphilis Surveillance Stage (CS) |
2.16.840.1.114222.4.11.7220 | Pregnancy Treatment Stage (NND) |
2.16.840.1.114222.4.11.7221 | Syphilis Treatment Mother (CS) |
2.16.840.1.114222.4.11.7223 | Birth Status (NND) |
2.16.840.1.114222.4.11.7224 | Darkfield DFA Result (CS) |
2.16.840.1.114222.4.11.7225 | Signs Symptoms (CS) |
2.16.840.1.114222.4.11.7226 | X-Ray Result (CS) |
2.16.840.1.114222.4.11.7227 | VDRL Test Result (NND) |
2.16.840.1.114222.4.11.7228 | CSF WBC Protein Result (NND) |
2.16.840.1.114222.4.11.7229 | Syphilis Treatment Infant (CS) |
2.16.840.1.114222.4.11.7247 | Symptoms (EVD Triage) |
2.16.840.1.114222.4.11.7249 | Exposure Risk (EVD) |
2.16.840.1.114222.4.11.7265 | Duration Unit |
2.16.840.1.114222.4.11.7269 | Reason for Missing Test (NND) |
2.16.840.1.114222.4.11.7270 | Lab Test Result Interpretation (NND) |
2.16.840.1.114222.4.11.7279 | Non-Treponemal Test Result (STD) |
2.16.840.1.114222.4.11.7282 | Complications (Mumps) |
2.16.840.1.114222.4.11.7283 | Signs and Symptoms (Mumps) |
2.16.840.1.114222.4.11.7284 | Signs and Symptoms (Pertussis) |
2.16.840.1.114222.4.11.7285 | Complications (Pertussis) |
2.16.840.1.114222.4.11.7329 | Type of Testing at CDC (NND) |
2.16.840.1.114222.4.11.7330 | Performing Laboratory Type (VPD) |
2.16.840.1.114222.4.11.7331 | Vaccine Administered (MMR) |
2.16.840.1.114222.4.11.7332 | Setting of Further Spread |
2.16.840.1.114222.4.11.7333 | Timing of Maternal Treatment (NND) |
2.16.840.1.114222.4.11.7334 | Lab Test Interpretation (Pertussis) |
2.16.840.1.114222.4.11.7335 | Vaccine Administered (Pertussis) |
2.16.840.1.114222.4.11.7359 | Point of Origin (NCHS) |
2.16.840.1.114222.4.11.7361 | Disposition OPD (NCHS) |
2.16.840.1.114222.4.11.7362 | Follow-up Attempt Outcome (NCHS) |
2.16.840.1.114222.4.11.7365 | Priority (Type) of Admission or Visit (NCHS) |
2.16.840.1.114222.4.11.7369 | Present on Admission (NCHS) |
2.16.840.1.114222.4.11.7372 | Time Units (NCHS) |
2.16.840.1.114222.4.11.7373 | Race (NCHS) |
2.16.840.1.114222.4.11.7374 | Place of Injury (NCHS) |
2.16.840.1.114222.4.11.7375 | Ethnicity Group (NCHS) |
2.16.840.1.114222.4.11.7376 | Ethnicity Detail (NCHS) |
2.16.840.1.114222.4.11.7379 | Methods of Disposition (NCHS) |
2.16.840.1.114222.4.11.7385 | Decedent Education Level (NCHS) |
2.16.840.1.114222.4.11.7422 | Fetal Death Cause or Condition (NCHS) |
2.16.840.1.114222.4.11.7437 | Disposition ED (NCHS) |
2.16.840.1.114222.4.11.7441 | Neurological Manifestation (STD) |
2.16.840.1.114222.4.11.7446 | States Territories Provinces (NCHS) |
2.16.840.1.114222.4.11.7448 | Vaccine Type (NND) |
2.16.840.1.114222.4.11.7450 | Vaccine Event Information Source (NND) |
2.16.840.1.114222.4.11.7451 | Type of Testing at CDC (VZ) |
2.16.840.1.114222.4.11.7452 | Age Unit (NND) |
2.16.840.1.114222.4.11.7453 | Body Region(s) of Rash |
2.16.840.1.114222.4.11.7454 | Character of Lesions |
2.16.840.1.114222.4.11.7473 | Diagnostic Lab Test Findings (NND) |
2.16.840.1.114222.4.11.7474 | Type of Complication (VZ) |
2.16.840.1.114222.4.11.7478 | Serotype (Dengue) |
2.16.840.1.114222.4.11.7486 | Yes No Not Applicable (NCHS) |
2.16.840.1.114222.4.11.7487 | Reason for Hospitalization (VZ) |
2.16.840.1.114222.4.11.7490 | Clinical Syndrome - Secondary (Arbovirus) |
2.16.840.1.114222.4.11.7495 | Serotype (Arbovirus) |
2.16.840.1.114222.4.11.7537 | Duration Unit (1) |
2.16.840.1.114222.4.11.7538 | Type of Complication (Babesiosis) |
2.16.840.1.114222.4.11.7539 | Medication Treatment (Babesiosis) |
2.16.840.1.114222.4.11.7540 | Blood Product |
2.16.840.1.114222.4.11.7541 | Clinical Manifestations (Babesiosis) |
2.16.840.1.114222.4.11.7544 | Outdoor Activities |
2.16.840.1.114222.4.11.7551 | Test Result Coded Qualitative |
2.16.840.1.114222.4.11.7553 | Specimen Type AST (STD) |
2.16.840.1.114222.4.11.7554 | Specimen Collection Site AST (STD) |
2.16.840.1.114222.4.11.756 | Gender Identity |
2.16.840.1.114222.4.11.7563 | Sexual Orientation |
2.16.840.1.114222.4.11.7582 | Vital Records Education Level (NCHS) |
2.16.840.1.114222.4.11.7585 | Fetal Remains Disposition Method (NCHS) |
2.16.840.1.114222.4.11.7607 | Type of Testing at CDC |
2.16.840.1.114222.4.11.7608 | Type Of Complication (CRS) |
2.16.840.1.114222.4.11.7609 | Sexual Orientation (STD) |
2.16.840.1.114222.4.11.7610 | Gender Identity (STD) |
2.16.840.1.114222.4.11.7611 | Clinical Manifestations (STD) |
2.16.840.1.114222.4.11.7612 | Late Clinical Manifestation (STD) |
2.16.840.1.114222.4.11.7615 | Pre-Pregnancy SerologicalTestInterp (CRS) |
2.16.840.1.114222.4.11.7616 | Specimen From Mother Or Infant (CRS) |
2.16.840.1.114222.4.11.7617 | Organism (FDD) |
2.16.840.1.114222.4.11.7618 | Yes No Unknown Refused (NND) |
2.16.840.1.114222.4.11.7619 | Antibiotics (FDD) |
2.16.840.1.114222.4.11.7620 | Antacids (FDD) |
2.16.840.1.114222.4.11.7621 | Signs and Symptoms (FDD) |
2.16.840.1.114222.4.11.7623 | Test Method (FDD) |
2.16.840.1.114222.4.11.7625 | Test Type (FDD) |
2.16.840.1.114222.4.11.7626 | Test Result (FDD) |
2.16.840.1.114222.4.11.7627 | Specimen Collection Source (FDD) |
2.16.840.1.114222.4.11.7628 | Yes No Unknown Maybe (FDD) |
2.16.840.1.114222.4.11.7629 | Yes No Don't Know Maybe (FDD) |
2.16.840.1.114222.4.11.7630 | Drinking Water (FDD) |
2.16.840.1.114222.4.11.7631 | Recreational H2O Treatment (FDD) |
2.16.840.1.114222.4.11.7632 | Raw Unpasteurized Products (FDD) |
2.16.840.1.114222.4.11.7633 | Day Care Setting (FDD) |
2.16.840.1.114222.4.11.7634 | Sexual Contact (FDD) |
2.16.840.1.114222.4.11.7635 | Medication Administered (FDD) |
2.16.840.1.114222.4.11.7636 | Medical History (FDD) |
2.16.840.1.114222.4.11.7637 | Seafood Preparation (FDD) |
2.16.840.1.114222.4.11.7638 | Seafood Source (FDD) |
2.16.840.1.114222.4.11.7639 | Shellfish Distributed (FDD) |
2.16.840.1.114222.4.11.7640 | Improper Handling Storage (FDD) |
2.16.840.1.114222.4.11.7644 | Vibrio Cholera Serotype (FDD) |
2.16.840.1.114222.4.11.7645 | Vibrio Cholera Biotype (FDD) |
2.16.840.1.114222.4.11.7649 | Signs and Symptoms (Rubella) |
2.16.840.1.114222.4.11.7650 | Type Of Complication (Rubella) |
2.16.840.1.114222.4.11.7651 | Previous Case Diagnosed By (Rubella) |
2.16.840.1.114222.4.11.7653 | Specimen Type (CRS) |
2.16.840.1.114222.4.11.7655 | PCR Specimen Source (CRS) |
2.16.840.1.114222.4.11.7656 | Specimen Source (Rubella) |
2.16.840.1.114222.4.11.7657 | Specimen Type (Rubella) |
2.16.840.1.114222.4.11.7659 | Type of Testing at CDC(Rubella) |
2.16.840.1.114222.4.11.7660 | Type of Complication (Measles) |
2.16.840.1.114222.4.11.7662 | Signs and Symptoms (Measles) |
2.16.840.1.114222.4.11.7666 | Signs and Symptoms (Trich) |
2.16.840.1.114222.4.11.7668 | Meat Consumed Type (Trich) |
2.16.840.1.114222.4.11.7669 | Food Processing Method (Trich) |
2.16.840.1.114222.4.11.7670 | Meat Purchase Info (Trich) |
2.16.840.1.114222.4.11.7671 | Food Cooking Method (Trich) |
2.16.840.1.114222.4.11.7672 | Performing Lab Type (Trich) |
2.16.840.1.114222.4.11.7674 | Lab Test Interpretation (Trich) |
2.16.840.1.114222.4.11.7675 | Specimen type (Trich) |
2.16.840.1.114222.4.11.7676 | Strain Type (Trich) |
2.16.840.1.114222.4.11.7678 | Discharge Location (RIBD) |
2.16.840.1.114222.4.11.7679 | Pregnancy Status (RIBD) |
2.16.840.1.114222.4.11.7680 | Fetal Outcome (RIBD) |
2.16.840.1.114222.4.11.7681 | Underlying Condition (RIBD) |
2.16.840.1.114222.4.11.7682 | Smoking Status (RIBD) |
2.16.840.1.114222.4.11.7683 | Substance Abuse (RIBD) |
2.16.840.1.114222.4.11.7684 | Mode of Delivery (RIBD) |
2.16.840.1.114222.4.11.7686 | Microorganism (RIBD) |
2.16.840.1.114222.4.11.7687 | Performing Lab Type (RIBD) |
2.16.840.1.114222.4.11.7688 | Vaccine Type (RIBD) |
2.16.840.1.114222.4.11.7689 | Vaccination Information Source (RIBD) |
2.16.840.1.114222.4.11.7691 | GAS Risk Factor Interval (RIBD) |
2.16.840.1.114222.4.11.7693 | Antibiotic Received (RIBD) |
2.16.840.1.114222.4.11.7695 | Antibiotic Reason (RIBD) |
2.16.840.1.114222.4.11.7696 | Detection Method (RIBD) |
2.16.840.1.114222.4.11.7697 | Birth Location (RIBD) |
2.16.840.1.114222.4.11.7698 | Gestational Age Determination (RIBD) |
2.16.840.1.114222.4.11.7699 | Susceptibility Data NA (RIBD) |
2.16.840.1.114222.4.11.7700 | AR Agent (RIBD) |
2.16.840.1.114222.4.11.7702 | ATI Method (RIBD) |
2.16.840.1.114222.4.11.7704 | Susceptibility Interpretation (RIBD) |
2.16.840.1.114222.4.11.7706 | Sequelae (RIBD) |
2.16.840.1.114222.4.11.7709 | Delivery Type (RIBD) |
2.16.840.1.114222.4.11.7710 | Medication Pre-Treatment (RIBD) |
2.16.840.1.114222.4.11.7711 | Contact Type (RIBD) |
2.16.840.1.114222.4.11.7712 | School Year (RIBD) |
2.16.840.1.114222.4.11.7713 | College Living Situation (RIBD) |
2.16.840.1.114222.4.11.7715 | Legionella Exposure (RIBD) |
2.16.840.1.114222.4.11.7716 | Definitely Possibly No (RIBD) |
2.16.840.1.114222.4.11.7717 | Legionella Exposure Setting (RIBD) |
2.16.840.1.114222.4.11.7718 | Healthcare Exposure Type (RIBD) |
2.16.840.1.114222.4.11.7719 | Facility Type (RIBD) |
2.16.840.1.114222.4.11.7720 | Water Source (RIBD) |
2.16.840.1.114222.4.11.7721 | Cruise Line (RIBD) |
2.16.840.1.114222.4.11.7722 | Titer Test Type (RIBD) |
2.16.840.1.114222.4.11.7723 | Signs and Symptoms (RIBD) |
2.16.840.1.114222.4.11.7724 | Personal Protective Equipment (RIBD) |
2.16.840.1.114222.4.11.7725 | Respiratory Protective Equipment (RIBD) |
2.16.840.1.114222.4.11.7726 | Glove Material (RIBD) |
2.16.840.1.114222.4.11.7727 | Titer Test Method (RIBD) |
2.16.840.1.114222.4.11.7728 | Bird Type (RIBD) |
2.16.840.1.114222.4.11.7729 | Establishment Type (RIBD) |
2.16.840.1.114222.4.11.7730 | Residence Location (RIBD) |
2.16.840.1.114222.4.11.7731 | Insurance Type (RIBD) |
2.16.840.1.114222.4.11.7732 | Infection Type (RIBD) |
2.16.840.1.114222.4.11.7733 | Lab Test Method (RIBD) |
2.16.840.1.114222.4.11.7734 | Lab Test Interpretation (RIBD) |
2.16.840.1.114222.4.11.7735 | SPN/IPD Serotype (RIBD) |
2.16.840.1.114222.4.11.7736 | Serotype Method (RIBD) |
2.16.840.1.114222.4.11.7737 | Legionellosis Serogroup (RIBD) |
2.16.840.1.114222.4.11.7740 | Colony Count Magnitude |
2.16.840.1.114222.4.11.7744 | Lab Test Interpretation (TB) |
2.16.840.1.114222.4.11.7745 | Type of Radiology Study |
2.16.840.1.114222.4.11.7746 | Result of Radiology Study (TB) |
2.16.840.1.114222.4.11.7747 | Diabetes Status |
2.16.840.1.114222.4.11.7748 | Epidemiological Risk Factors (TB) |
2.16.840.1.114222.4.11.7751 | Type of Link (TB) |
2.16.840.1.114222.4.11.7755 | LTBI Drug Regimen (TB) |
2.16.840.1.114222.4.11.7756 | Reason LTBI Not Started (TB) |
2.16.840.1.114222.4.11.7757 | Reason LTBI Treatment Stopped (TB) |
2.16.840.1.114222.4.11.7759 | Medication (TB) |
2.16.840.1.114222.4.11.7761 | Susceptibility Test Interpretation (TB) |
2.16.840.1.114222.4.11.7762 | Susceptibility Test Method (TB) |
2.16.840.1.114222.4.11.7763 | Gene Name (TB) |
2.16.840.1.114222.4.11.7764 | Molecular Test Results (TB) |
2.16.840.1.114222.4.11.7765 | Molecular Indel (TB) |
2.16.840.1.114222.4.11.7766 | Molecular Test Methods (TB) |
2.16.840.1.114222.4.11.7767 | Reason Not Treated with RIPE (TB) |
2.16.840.1.114222.4.11.7769 | Final Treatment Outcome (TB) |
2.16.840.1.114222.4.11.7772 | Side Effect of Treatment (TB) |
2.16.840.1.114222.4.11.7773 | Serogroup Method (RIBD) |
2.16.840.1.114222.4.11.7774 | Specimen Type (RIBD) |
2.16.840.1.114222.4.11.7778 | Specimen Site (FDD) |
2.16.840.1.114222.4.11.7779 | Condition Status (FDD) |
2.16.840.1.114222.4.11.7785 | Extended Race Group (Listeria) |
2.16.840.1.114222.4.11.7787 | Food Allergy (Listeria) |
2.16.840.1.114222.4.11.7789 | Fruit (Listeria) |
2.16.840.1.114222.4.11.7790 | Heated Food (Listeria) |
2.16.840.1.114222.4.11.7791 | Hispanic Ethnic Group (Listeria) |
2.16.840.1.114222.4.11.7792 | Illness (Listeria) |
2.16.840.1.114222.4.11.7793 | Likely Contact (Listeria) |
2.16.840.1.114222.4.11.7794 | LikelyAte (Listeria) |
2.16.840.1.114222.4.11.7795 | Medical History (Listeria) |
2.16.840.1.114222.4.11.7796 | Patient Type (Listeria) |
2.16.840.1.114222.4.11.7797 | Birth Location (Listeria) |
2.16.840.1.114222.4.11.7798 | Pregnancy Outcome (Listeria) |
2.16.840.1.114222.4.11.7799 | Reason Not Interviewed (Listeria) |
2.16.840.1.114222.4.11.7800 | Respondent (Listeria) |
2.16.840.1.114222.4.11.7801 | Signs and Symptoms (Listeria) |
2.16.840.1.114222.4.11.7802 | Specimen Type (Listeria) |
2.16.840.1.114222.4.11.7803 | Yes No Unknown Refused (Listeria) |
2.16.840.1.114222.4.11.7804 | Patient Outcome (Listeria) |
2.16.840.1.114222.4.11.7806 | Assisted Living Exposure Type (RIBD) |
2.16.840.1.114222.4.11.7808 | N. meningitidis Serogroup (RIBD) |
2.16.840.1.114222.4.11.7809 | H. influenzae Serotype (RIBD) |
2.16.840.1.114222.4.11.7812 | Case Type (CP-CRE) |
2.16.840.1.114222.4.11.7813 | Specimen Source (CP-CRE) |
2.16.840.1.114222.4.11.7823 | Lab Test Interpretation (Legionellosis) |
2.16.840.1.114222.4.11.7825 | Gene Name (CP-CRE) |
2.16.840.1.114222.4.11.7826 | Specimen Source Site (VPD) |
2.16.840.1.114222.4.11.7832 | Clinical Manifestation (TBRD) |
2.16.840.1.114222.4.11.7833 | Complications (TBRD) |
2.16.840.1.114222.4.11.7834 | Medication Received (TBRD) |
2.16.840.1.114222.4.11.7836 | Organism (TBRD) |
2.16.840.1.114222.4.11.7837 | Coinfection Type (TBRD) |
2.16.840.1.114222.4.11.7838 | Specimen Type (TBRD) |
2.16.840.1.114222.4.11.7839 | Medication Received (Lyme) |
2.16.840.1.114222.4.11.7840 | Clinical Manifestations (Lyme) |
2.16.840.1.114222.4.11.7841 | Specimen Type (Lyme) |
2.16.840.1.114222.4.11.7843 | Organism (Lyme) |
2.16.840.1.114222.4.11.7845 | Serotype Master (RIBD) |
2.16.840.1.114222.4.11.7846 | Lab Test Interpretation Master (RIBD) |
2.16.840.1.114222.4.11.7848 | Exposure Setting Master (RIBD) |
2.16.840.1.114222.4.11.7849 | Usual Occupation and Industry (TB) |
2.16.840.1.114222.4.11.7850 | Organism (CP-CRE) |
2.16.840.1.114222.4.11.7851 | Contact Type (FDD) |
2.16.840.1.114222.4.11.7852 | Geographic Location |
2.16.840.1.114222.4.11.7861 | Death Reporting Decedent and Certificate Identifier Type (HL70203) (NCHS) |
2.16.840.1.114222.4.11.7862 | Test Result (CP-CRE) |
2.16.840.1.114222.4.11.7864 | Specimen Source (C. auris) |
2.16.840.1.114222.4.11.7866 | Lab Test Method (MDRO) |
2.16.840.1.114222.4.11.7868 | Type of Long Term Care Facility (C. auris) |
2.16.840.1.114222.4.11.7869 | Specimen Collection Setting Type (C. auris) |
2.16.840.1.114222.4.11.7870 | Type of Co-infection (C. auris) |
2.16.840.1.114222.4.11.7874 | Poison Control Center Record (CO) |
2.16.840.1.114222.4.11.7875 | Workers Compensation Record (CO) |
2.16.840.1.114222.4.11.7876 | Intent of Exposure (CO) |
2.16.840.1.114222.4.11.7877 | Extreme Weather Type (CO) |
2.16.840.1.114222.4.11.7878 | Exposure Source (CO) |
2.16.840.1.114222.4.11.7879 | Treatment Type (CO) |
2.16.840.1.114222.4.11.7880 | Education (CO) |
2.16.840.1.114222.4.11.7881 | Generator Location (CO) |
2.16.840.1.114222.4.11.7882 | Generator Distance (CO) |
2.16.840.1.114222.4.11.7883 | Person/Organization Taking CO Reading (CO) |
2.16.840.1.114222.4.11.7884 | Exposure Site Category (CO) |
2.16.840.1.114222.4.11.7885 | Public Site of Exposure (CO) |
2.16.840.1.114222.4.11.7886 | Treatment Location (CO) |
2.16.840.1.114222.4.11.7887 | Underlying Conditions (CO) |
2.16.840.1.114222.4.11.7888 | Signs and Symptoms (CO) |
2.16.840.1.114222.4.11.7889 | ICD Codes List (CO) |
2.16.840.1.114222.4.11.7890 | Treatment Site (CO) |
2.16.840.1.114222.4.11.7891 | Data Reporting Source (CO) |
2.16.840.1.114222.4.11.7896 | Residential Site of Exposure (CO) |
2.16.840.1.114222.4.11.7907 | Ethnicity (ARLN) |
2.16.840.1.114222.4.11.7908 | Gender (ARLN) |
2.16.840.1.114222.4.11.7914 | Acinetobacter culture result (ARLN) |
2.16.840.1.114222.4.11.7921 | Specimen type (ARLN) |
2.16.840.1.114222.4.11.7922 | Microorganism (ARLN) |
2.16.840.1.114222.4.11.7923 | Medication Treatment (STD) |
2.16.840.1.114222.4.11.7925 | Type of Complication (STD) |
2.16.840.1.114222.4.11.7926 | Number of Cigarettes Smoked per Day (CO) |
2.16.840.1.114222.4.11.7927 | Dose Unit (STD) |
2.16.840.1.114222.4.11.7928 | Lab Test Result Qualitative (Syphilis) |
2.16.840.1.114222.4.11.7929 | Medication Route (STD) |
2.16.840.1.114222.4.11.7930 | Route of Administration (STD) |
2.16.840.1.114222.4.11.7931 | Medication Frequency Unit (STD) |
2.16.840.1.114222.4.11.7932 | Duration Units (STD) |
2.16.840.1.114222.4.11.7934 | Microorganism (STD) |
2.16.840.1.114222.4.11.7936 | Contact Type (COVID-19) |
2.16.840.1.114222.4.11.7938 | Detection Method (COVID-19) |
2.16.840.1.114222.4.11.7939 | Residence Type (COVID-19) |
2.16.840.1.114222.4.11.7940 | Healthcare Occupation (COVID-19) |
2.16.840.1.114222.4.11.7941 | Job Setting (COVID-19) |
2.16.840.1.114222.4.11.7942 | Exposure Setting (COVID-19) |
2.16.840.1.114222.4.11.7943 | Data Reporting Source (COVID-19) |
2.16.840.1.114222.4.11.7944 | Signs and Symptoms (COVID-19) |
2.16.840.1.114222.4.11.7945 | Clinical Finding (COVID-19) |
2.16.840.1.114222.4.11.7946 | Animal Type (COVID-19) |
2.16.840.1.114222.4.11.7947 | Risk Factor (COVID-19) |
2.16.840.1.114222.4.11.7949 | Treatment Type (COVID-19) |
2.16.840.1.114222.4.11.7950 | Yes No Unknown NA (NND) |
2.16.840.1.114222.4.11.7951 | Reason for Test (COVID-19) |
2.16.840.1.114222.4.11.7952 | Tribe Name (NND) |
2.16.840.1.114222.4.11.7953 | Critical Infrastructure Sector (NND) |
2.16.840.1.114222.4.11.7954 | Medication Administered (Hansen) |
2.16.840.1.114222.4.11.7956 | Type of Leprosy (Hansen) |
2.16.840.1.114222.4.11.7957 | Relationship (Hansen) |
2.16.840.1.114222.4.11.7958 | Hospital Procedure (Leptospirosis) |
2.16.840.1.114222.4.11.7959 | Underlying Condition(s) (Leptospirosis) |
2.16.840.1.114222.4.11.7960 | Disease Outcome Type (Leptospirosis) |
2.16.840.1.114222.4.11.7961 | Medication (Leptospirosis) |
2.16.840.1.114222.4.11.7962 | Contact Type (Brucellosis) |
2.16.840.1.114222.4.11.7963 | Medication Administered (Anthrax) |
2.16.840.1.114222.4.11.7965 | Sick Animal Type (Leptospirosis) |
2.16.840.1.114222.4.11.7966 | Rodent Type (Leptospirosis) |
2.16.840.1.114222.4.11.7967 | Animal Type (Leptospirosis) |
2.16.840.1.114222.4.11.7968 | Clinical Manifestations (Leptospirosis) |
2.16.840.1.114222.4.11.7969 | Specimen Type (Brucellosis) |
2.16.840.1.114222.4.11.7970 | Disease Stage (Brucellosis) |
2.16.840.1.114222.4.11.7971 | Animal Type (Brucellosis) |
2.16.840.1.114222.4.11.7972 | Medication (Brucellosis) |
2.16.840.1.114222.4.11.7973 | Diagnostic Test Finding (Anthrax) |
2.16.840.1.114222.4.11.7974 | Specimen Type (Leptospirosis) |
2.16.840.1.114222.4.11.7975 | Specimen Source Site (Leptospirosis) |
2.16.840.1.114222.4.11.7976 | Test Titer Type (Brucellosis) |
2.16.840.1.114222.4.11.7977 | Brucella Exposure (Brucellosis) |
2.16.840.1.114222.4.11.7978 | Exposure Risk (Brucellosis) |
2.16.840.1.114222.4.11.7979 | Previous Treatment Duration (Hansen) |
2.16.840.1.114222.4.11.7980 | Patient Case Status (Hansen) |
2.16.840.1.114222.4.11.7981 | Animal Ownership (Brucellosis) |
2.16.840.1.114222.4.11.7982 | Vaccine Exposure (Brucellosis) |
2.16.840.1.114222.4.11.7984 | Hospital Procedure (Anthrax) |
2.16.840.1.114222.4.11.7985 | Actual Route of Administration (Anthrax) |
2.16.840.1.114222.4.11.7986 | Performing Lab Type (Anthrax) |
2.16.840.1.114222.4.11.7987 | Country of Product Acquisition (Brucellosis) |
2.16.840.1.114222.4.11.7988 | Location Type (Leptospirosis) |
2.16.840.1.114222.4.11.7989 | Clinical Outcome (Anthrax) |
2.16.840.1.114222.4.11.7990 | Specimen Type (Anthrax) |
2.16.840.1.114222.4.11.7991 | Procedure Type (Anthrax) |
2.16.840.1.114222.4.11.7992 | Public TransportationType (Anthrax) |
2.16.840.1.114222.4.11.7994 | Exposure Type (Leptospirosis) |
2.16.840.1.114222.4.11.7995 | Diet Type (Anthrax) |
2.16.840.1.114222.4.11.7996 | Post-exposure or Treatment (NND) |
2.16.840.1.114222.4.11.7997 | Treatment Type (Anthrax) |
2.16.840.1.114222.4.11.7999 | Animal Type (Anthrax) |
2.16.840.1.114222.4.11.8000 | Test Results Anthrax |
2.16.840.1.114222.4.11.8002 | Reason Medication Not Completed (BSP) |
2.16.840.1.114222.4.11.8003 | Smoking Status (Anthrax) |
2.16.840.1.114222.4.11.8004 | Test Results (Brucellosis) |
2.16.840.1.114222.4.11.8005 | Antimicrobials (Anthrax) |
2.16.840.1.114222.4.11.8006 | Contact Type (Anthrax) |
2.16.840.1.114222.4.11.8007 | Clinical Manifestations (Brucellosis) |
2.16.840.1.114222.4.11.8008 | Clinical Manifestations (Anthrax) |
2.16.840.1.114222.4.11.8009 | Exposure Location (Brucellosis) |
2.16.840.1.114222.4.11.8010 | Organism Name (Brucellosis) |
2.16.840.1.114222.4.11.8011 | Activity Type (Leptospirosis) |
2.16.840.1.114222.4.11.8012 | Activity Type (Brucellosis) |
2.16.840.1.114222.4.11.8013 | Exposure Source (Anthrax) |
2.16.840.1.114222.4.11.8014 | Activity Type Anthrax |
2.16.840.1.114222.4.11.8015 | Food Product Consumed (Brucellosis) |
2.16.840.1.114222.4.11.8016 | Fresh Water or Mud Type (Leptospirosis) |
2.16.840.1.114222.4.11.8017 | Exposure Source (Brucellosis) |
2.16.840.1.114222.4.11.8021 | Total Doses of Vaccine (Anthrax) |
2.16.840.1.114222.4.11.8024 | Medication Completed (Brucellosis) |
2.16.840.1.114222.4.11.8029 | Division Vital Statistics (County) |
2.16.840.1.114222.4.11.8030 | Lab Test (Hansen) |
2.16.840.1.114222.4.11.8033 | Frequency Duration Unit (Hansen) |
2.16.840.1.114222.4.11.8036 | Antibiotic Dose Units (Brucellosis) |
2.16.840.1.114222.4.11.8037 | Test Type (Brucellosis) |
2.16.840.1.114222.4.11.8038 | Specimen Source Site (Brucellosis) |
2.16.840.1.114222.4.11.8039 | Test Results (Leptospirosis) |
2.16.840.1.114222.4.11.8040 | Pregnancy Outcome (Leptospirosis) |
2.16.840.1.114222.4.11.8041 | Lab Test Type (Leptospirosis) |
2.16.840.1.114222.4.11.8042 | Test Result (Hepatitis A) |
2.16.840.1.114222.4.11.8043 | HBeAg Test Result (Hepatitis B Perinatal) |
2.16.840.1.114222.4.11.8044 | Infant Nucleic Acid Test Result (Hepatitis C) |
2.16.840.1.114222.4.11.8045 | Infant HCV Antigen Test Result (Hepatitis C) |
2.16.840.1.114222.4.11.8046 | Mother Nucleic Acid Test Result (Perinatal Hep) |
2.16.840.1.114222.4.11.8048 | Common-Source Outbreak (Hepatitis B) |
2.16.840.1.114222.4.11.8049 | Common-Source Outbreak (Hepatitis C) |
2.16.840.1.114222.4.11.8051 | Patient Epidemiological Risk Factors (Hepatitis A) |
2.16.840.1.114222.4.11.8052 | Patient Epidemiological Risk Factors (Hepatitis B) |
2.16.840.1.114222.4.11.8053 | Patient Epidemiological Risk Factors (Hepatitis C) |
2.16.840.1.114222.4.11.8054 | Alanine aminotransferase (ALT) Result (Hepatitis) |
2.16.840.1.114222.4.11.8055 | Source of Laboratory Test (Hepatitis) |
2.16.840.1.114222.4.11.8056 | HBsAg Test Result (Hepatitis B Perinatal) |
2.16.840.1.114222.4.11.8057 | Infant Anti-HCVTest Result (Hepatitis C Perinatal) |
2.16.840.1.114222.4.11.8060 | Test Result (Hepatitis) |
2.16.840.1.114222.4.11.8061 | HBV DNA Test Result (Hepatitis B Perinatal) |
2.16.840.1.114222.4.11.8062 | Gender Identity (USCDI) |
2.16.840.1.114222.4.11.8063 | Sexual Orientation (USCDI) |
2.16.840.1.114222.4.11.8064 | Travel Purpose (CDC) |
2.16.840.1.114222.4.11.828 | Country |
2.16.840.1.114222.4.11.829 | County |
2.16.840.1.114222.4.11.831 | Language |
2.16.840.1.114222.4.11.875 | Null Flavor (HL7 V3) |
2.16.840.1.114222.4.11.878 | Age unit |
2.16.840.1.114222.4.11.888 | Yes No Unknown (YNU) |
2.16.840.1.114222.4.11.921 | Emergency Department Acuity |
2.16.840.1.114222.4.11.929 | Positive Negative Unknown Not Done |
2.16.840.1.114222.4.11.930 | Chest XRay Result |
2.16.840.1.114222.4.11.931 | Vaccine Not Given Reason |
2.16.840.1.114222.4.11.941 | Susceptibility Result |
2.16.840.1.114222.4.11.950 | Passed Failed Unknown |
2.16.840.1.114222.4.11.957 | Abnormal Chest X-Ray Finding (TB) |
2.16.840.1.114222.4.11.959 | Additional Site of Disease (TB) |
2.16.840.1.114222.4.11.968 | Case Classification Status |
2.16.840.1.114222.4.11.970 | Case Investigation Status |
2.16.840.1.114222.4.11.979 | Type of Correctional Facility |
2.16.840.1.114222.4.11.980 | Diagnosed by (VZ) |
2.16.840.1.114222.4.11.981 | Diagnosed Pneumonia By (VZ) |
2.16.840.1.114222.4.11.982 | Directly Observed Therapy (TB) |
2.16.840.1.114222.4.11.983 | Sites of Directly Observed Therapy (TB) |
2.16.840.1.114222.4.11.985 | Employment Status |
2.16.840.1.114222.4.11.992 | Epilinked Case Type (VZ) |
2.16.840.1.114222.4.11.994 | General Condition Status |
2.16.840.1.114222.4.11.995 | Health Care Practice Type (TB) |
2.16.840.1.114222.4.11.997 | HIV Diagnosis Based On |
2.16.840.1.114222.4.11.998 | HIV Status |
2.16.840.1.114222.4.3.20 | Specimen Source Site (Anthrax) |
omb-race-category | OMB Race Categories |
fips-county-co | CO FIPS Counties |
birthsex | Birth Sex |
detailed-ethnicity | Detailed ethnicity |
detailed-race | Detailed Race |
encounter-special-courtesy | Special courtesy |
2.16.840.1.113762.1.4.1021.32 | Gender Identity |
omb-ethnicity-category | OMB Ethnicity Categories |
2.16.840.1.113883.2.4.3.11.60.20.77.11.9--20160407000000 | Aanvullende gebruiksinstructie |
2.16.840.1.113883.2.4.3.11.60.20.77.11.57--20241101000000 | Financiële Indicatiecode |
2.16.840.1.113883.2.4.3.11.60.20.77.11.47--20240131165054 | MedicatieToedieningRedenVanAfwijkenCodelijst |
2.16.840.1.113883.2.4.3.11.60.20.77.11.53--20220323181942 | PrikPlakLocatieCodeLijst |
2.16.840.1.113883.2.4.3.11.60.20.77.11.42--20221114132525 | RedenWijzigen-StakenCodelijst |
2.16.840.1.113883.2.4.3.11.60.20.77.11.54--20221114181621 | RedenWijzigen-StakenWDSCodelijst |
2.16.840.1.113883.2.4.3.11.60.20.77.11.43--20221115122002 | RedenWijzigen-StoppenGebruikCodelijst |
2.16.840.1.113883.2.4.3.11.60.20.77.11.49--20221115120643 | Toedieningsafspraak-RedenWijzigen-StakenCodelijst |
2.16.840.1.113883.2.4.3.11.60.40.2.9.12.4--20200901000000 | ZonodigCriteriumCodelijst |
be-vs-vaccination-administration-route | BeVSVaccineAdministrationRoute |
be-civilstate | BeCivilstate |
be-vs-vaccination-administration-route | Vaccine Administration Route |
eHDSIExceptionalValue | eHDSI Exceptional Value |
stationstyp | Stationstyp |
birthsex | Birth Sex |
AdministrationDevice | AdministrationDevice |
ConditionsDuringMeasurement | ConditionsDuringMeasurement |
DeviatingBreathingPattern | DeviatingBreathingPattern |
EstimatingMethod | EstimatingMethod |
FamilyComposition | FamilyComposition |
FamilyCompositionChild | FamilyCompositionChild |
FeedingTubeType | FeedingTubeType |
InfusionCatheterType | InfusionCatheterType |
LifeStance | LifeStance |
LineStatus | LineStatus |
StomaType | StomaType |
TypeOfDisorder | TypeOfDisorder |
UrineCatheterType | UrineCatheterType |
VisualAcuityMeasurementChart | VisualAcuityMeasurementChart |
VisualAcuityMeasurementDevice | VisualAcuityMeasurementDevice |
VisualAcuityType | VisualAcuityType |
WoundEdge | WoundEdge |
WoundType | WoundType |
OutbreakCategoryVS | Ausbruchskategorie-Werteliste |
OutbreakEnvironmentSettingVS | Infektionsumfeld |
OutbreakInfectionRouteVS | Infektionsweg |
YesNoNullFlavor | Ja, Nein, Nicht ermittelbar, Nicht erhoben Antworten |
NHSDigital-VaccineCode | NHS Digital Vaccine Code |
uds-plus-insurance-codes | Uds Plus Insurance Codes |
2.16.840.1.113883.2.4.3.11.60.26.11.7--20211028090253 | CategorieCodelijst |
2.16.840.1.113883.2.4.3.11.60.26.11.41--20240910090504 | StartRedenCodelijst |
2.16.840.1.113883.2.4.3.11.60.26.11.40--20240909075522 | StopRedenCodelijst |
2.16.840.1.113883.2.4.3.11.60.26.11.14--20231120120019 | WijzeVanVaststellenCodelijst |
PatientComorbidityHistory | Patient's comorbidity history ValueSet |
istat-comune | ISTAT - Comuni |
istat-provincia | ISTAT - Province |
statoCivile | Stato Civile |
yes-no-unknown-not-applicable | Yes No Unknown NotApplicable |
2.16.840.1.113762.1.4.1021.102 | Unknown or did not answer |
2.16.840.1.113762.1.4.1021.103 | Other or unknown or refused to answer |
2.16.840.1.113762.1.4.1021.24 | Birth Sex |
2.16.840.1.113762.1.4.1240.10 | Other Unknown Nulls |
2.16.840.1.113762.1.4.1240.11 | Sexual Orientation Including nulls and Data Absent Reason |
2.16.840.1.113762.1.4.1240.12 | Pregnancy Status Observation |
2.16.840.1.113762.1.4.1240.2 | No Healthcare Agent Included Reason |
2.16.840.1.113762.1.4.1267.25 | Detailed race including absence reasons. |
2.16.840.1.113883.1.11.10612 | Unknown Null |
2.16.840.1.113883.4.642.2.575 | Race Categories |
2.16.840.1.113883.4.642.40.2.48.1 | Detailed Ethnicity Including Absence Reasons |
2.16.840.1.113883.4.642.40.2.48.3 | Ethnicity Categories |
PolicyStatus | PolicyStatus |
No resources found
Note: links and images are rebased to the (stated) source
Generated Narrative: CodeSystem v3-NullFlavor
Language: en
Properties
This code system defines the following properties for its concepts
Name | Code | URI | Type | Description |
Specializes | Specializes | Coding | The child code is a more narrow version of the concept represented by the parent code. I.e. Every child concept is also a valid parent concept. Used to allow determination of subsumption. Must be transitive, irreflexive, antisymmetric. | |
Generalizes | Generalizes | Coding | Inverse of Specializes. Only included as a derived relationship. | |
internalId | internalId | http://terminology.hl7.org/CodeSystem/utg-concept-properties#v3-internal-id | code | The internal identifier for the concept in the HL7 Access database repository. |
Status | status | http://hl7.org/fhir/concept-properties#status | code | Designation of a concept's state. Normally is not populated unless the state is retired.. |
HL7 Concept Usage Notes | HL7usageNotes | http://terminology.hl7.org/CodeSystem/utg-concept-properties#HL7usageNotes | string | HL7 Concept Usage Notes |
Parent | subsumedBy | http://hl7.org/fhir/concept-properties#parent | code | The concept code of a parent concept |
Concepts
This case-sensitive code system http://terminology.hl7.org/CodeSystem/v3-NullFlavor
defines the following codes in a Is-A hierarchy:
Lvl | Code | Display | Definition | internalId | Status | HL7 Concept Usage Notes | Parent |
1 | NI | NoInformation | **Description:**The value is exceptional (missing, omitted, incomplete, improper). No information as to the reason for being an exceptional value is provided. This is the most general exceptional value. It is also the default exceptional value. | 10610 | active | ||
2 | INV | invalid | **Description:**The value as represented in the instance is not a member of the set of permitted data values in the constrained value domain of a variable. | 22656 | active | NI | |
3 | DER | derived | **Description:**An actual value may exist, but it must be derived from the provided information (usually an EXPR generic data type extension will be used to convey the derivation expressionexpression . | 22657 | active | INV | |
3 | OTH | other | **Description:**The actual value is not a member of the set of permitted data values in the constrained value domain of a variable. (e.g., concept not provided by required code system). Usage Notes: This flavor and its specializations are most commonly used with the CD datatype and its flavors. However, it may apply to *any* datatype where the constraints of the type are tighter than can be conveyed. For example, a PQ that is for a true measured amount whose units are not supported in UCUM, a need to convey a REAL when the type has been constrained to INT, etc. With coded datatypes, this null flavor may only be used if the vocabulary binding has a coding strength of CNE. By definition, all local codes and original text are part of the value set if the coding strength is CWE. | 10616 | active | This flavor and its specializations are most commonly used with the CD datatype and its flavors. However, it may apply to *any* datatype where the constraints of the type are tighter than can be conveyed. For example, a PQ that is for a true measured amount whose units are not supported in UCUM, a need to convey a REAL when the type has been constrained to INT, etc. With coded datatypes, this null flavor may only be used if the vocabulary binding has a coding strength of CNE. By definition, all local codes and original text are part of the value set if the coding strength is CWE. | INV |
4 | NINF | negative infinity | Negative infinity of numbers. | 10618 | active | OTH | |
4 | PINF | positive infinity | Positive infinity of numbers. | 10617 | active | OTH | |
3 | UNC | un-encoded | Description: The actual value has not yet been encoded within the approved value domain. Example: Original text or a local code has been specified but translation or encoding to the approved value set has not yet occurred due to limitations of the sending system. Original text has been captured for a PQ, but not attempt has been made to split the value and unit or to encode the unit in UCUM. Usage Notes: If it is known that it is not possible to encode the concept, OTH should be used instead. However, use of UNC does not necessarily guarantee the concept will be encodable, only that encoding has not been attempted. Data type properties such as original text and translations may be present when this null flavor is included. | 22185 | active | If it is known that it is not possible to encode the concept, OTH should be used instead. However, use of UNC does not necessarily guarantee the concept will be encodable, only that encoding has not been attempted. Data type properties such as original text and translations may be present when this null flavor is included. | INV |
2 | MSK | masked | There is information on this item available but it has not been provided by the sender due to security, privacy or other reasons. There may be an alternate mechanism for gaining access to this information. Note: using this null flavor does provide information that may be a breach of confidentiality, even though no detail data is provided. Its primary purpose is for those circumstances where it is necessary to inform the receiver that the information does exist without providing any detail. | 17932 | active | NI | |
2 | NA | not applicable | Known to have no proper value (e.g., last menstrual period for a male). | 10611 | active | NI | |
2 | UNK | unknown | **Description:**A proper value is applicable, but not known. Usage Notes: This means the actual value is not known. If the only thing that is unknown is how to properly express the value in the necessary constraints (value set, datatype, etc.), then the OTH or UNC flavor should be used. No properties should be included for a datatype with this property unless:
| 10612 | active | This means the actual value is not known. If the only thing that is unknown is how to properly express the value in the necessary constraints (value set, datatype, etc.), then the OTH or UNC flavor should be used. No properties should be included for a datatype with this property unless: Those properties themselves directly translate to a semantic of "unknown". (E.g. a local code sent as a translation that conveys 'unknown') Those properties further qualify the nature of what is unknown. (E.g. specifying a use code of "H" and a URL prefix of "tel:" to convey that it is the home phone number that is unknown.) | NI |
3 | ASKU | asked but unknown | Information was sought but not found (e.g., patient was asked but didn't know) | 10614 | active | UNK | |
4 | NAV | temporarily unavailable | Information is not available at this time but it is expected that it will be available later. | 10615 | active | ASKU, NAVU | |
3 | NASK | not asked | This information has not been sought (e.g., patient was not asked) | 10613 | active | UNK | |
3 | NAVU | Not available | Information is not available at this time (with no expectation regarding whether it will or will not be available in the future). | 23731 | active | UNK | |
4 | NAV | temporarily unavailable | |||||
3 | QS | Sufficient Quantity | **Description:**The specific quantity is not known, but is known to be non-zero and is not specified because it makes up the bulk of the material. e.g. 'Add 10mg of ingredient X, 50mg of ingredient Y, and sufficient quantity of water to 100mL.' The null flavor would be used to express the quantity of water. | 21436 | active | UNK | |
3 | TRC | trace | The content is greater than zero, but too small to be quantified. | 21386 | active | UNK | |
1 | NP | not present | Value is not present in a message. This is only defined in messages, never in application data! All values not present in the message must be replaced by the applicable default, or no-information (NI) as the default of all defaults. | 10619 | retired |
{ "resourceType": "CodeSystem", "id": "v3-NullFlavor", "language": "en", "text": { "status": "generated", "div": "<!-- snip (see above) -->" }, "url": "http://terminology.hl7.org/CodeSystem/v3-NullFlavor", "identifier": [ { "system": "urn:ietf:rfc:3986", "value": "urn:oid:2.16.840.1.113883.5.1008" } ], "version": "3.0.0", "name": "NullFlavor", "title": "NullFlavor", "status": "active", "experimental": false, "date": "2019-03-20", "publisher": "Health Level Seven International", "contact": [ { "telecom": [ { "system": "url", "value": "http://hl7.org" }, { "system": "email", "value": "hq@HL7.org" } ] } ], "description": "A collection of codes specifying why a valid value is not present.", "copyright": "This material derives from the HL7 Terminology THO. THO is copyright ©1989+ Health Level Seven International and is made available under the CC0 designation. For more licensing information see: https://terminology.hl7.org/license.html", "caseSensitive": true, "hierarchyMeaning": "is-a", "content": "complete", "property": [ { "extension": [ { "url": "http://terminology.hl7.org/StructureDefinition/ext-mif-relationship-symmetry", "valueCode": "antisymmetric" }, { "url": "http://terminology.hl7.org/StructureDefinition/ext-mif-relationship-transitivity", "valueCode": "transitive" }, { "url": "http://terminology.hl7.org/StructureDefinition/ext-mif-relationship-reflexivity", "valueCode": "irreflexive" }, { "url": "http://terminology.hl7.org/StructureDefinition/ext-mif-relationship-isNavigable", "valueBoolean": true }, { "url": "http://terminology.hl7.org/StructureDefinition/ext-mif-relationship-relationshipKind", "valueCode": "Specializes" }, { "url": "http://terminology.hl7.org/StructureDefinition/ext-mif-relationship-inverseName", "valueString": "Generalizes" } ], "code": "Specializes", "description": "The child code is a more narrow version of the concept represented by the parent code. I.e. Every child concept is also a valid parent concept. Used to allow determination of subsumption. Must be transitive, irreflexive, antisymmetric.", "type": "Coding" }, { "extension": [ { "url": "http://terminology.hl7.org/StructureDefinition/ext-mif-relationship-symmetry", "valueCode": "antisymmetric" }, { "url": "http://terminology.hl7.org/StructureDefinition/ext-mif-relationship-transitivity", "valueCode": "transitive" }, { "url": "http://terminology.hl7.org/StructureDefinition/ext-mif-relationship-reflexivity", "valueCode": "irreflexive" }, { "url": "http://terminology.hl7.org/StructureDefinition/ext-mif-relationship-isNavigable", "valueBoolean": true }, { "url": "http://terminology.hl7.org/StructureDefinition/ext-mif-relationship-relationshipKind", "valueCode": "Generalizes" }, { "url": "http://terminology.hl7.org/StructureDefinition/ext-mif-relationship-inverseName", "valueString": "Specializes" } ], "code": "Generalizes", "description": "Inverse of Specializes. Only included as a derived relationship.", "type": "Coding" }, { "code": "internalId", "uri": "http://terminology.hl7.org/CodeSystem/utg-concept-properties#v3-internal-id", "description": "The internal identifier for the concept in the HL7 Access database repository.", "type": "code" }, { "code": "status", "uri": "http://hl7.org/fhir/concept-properties#status", "description": "Designation of a concept's state. Normally is not populated unless the state is retired..", "type": "code" }, { "code": "HL7usageNotes", "uri": "http://terminology.hl7.org/CodeSystem/utg-concept-properties#HL7usageNotes", "description": "HL7 Concept Usage Notes", "type": "string" }, { "code": "subsumedBy", "uri": "http://hl7.org/fhir/concept-properties#parent", "description": "The concept code of a parent concept", "type": "code" } ], "concept": [ { "code": "NI", "display": "NoInformation", "definition": "**Description:**The value is exceptional (missing, omitted, incomplete, improper). No information as to the reason for being an exceptional value is provided. This is the most general exceptional value. It is also the default exceptional value.", "property": [ { "code": "status", "valueCode": "active" }, { "code": "internalId", "valueCode": "10610" } ] }, { "code": "NP", "display": "not present", "definition": "Value is not present in a message. This is only defined in messages, never in application data! All values not present in the message must be replaced by the applicable default, or no-information (NI) as the default of all defaults.", "property": [ { "code": "status", "valueCode": "retired" }, { "code": "internalId", "valueCode": "10619" } ] }, { "code": "NAV", "display": "temporarily unavailable", "definition": "Information is not available at this time but it is expected that it will be available later.", "property": [ { "code": "status", "valueCode": "active" }, { "code": "internalId", "valueCode": "10615" }, { "code": "subsumedBy", "valueCode": "ASKU" }, { "code": "subsumedBy", "valueCode": "NAVU" } ] }, { "code": "DER", "display": "derived", "definition": "**Description:**An actual value may exist, but it must be derived from the provided information (usually an EXPR generic data type extension will be used to convey the derivation expressionexpression .", "property": [ { "code": "status", "valueCode": "active" }, { "code": "internalId", "valueCode": "22657" }, { "code": "subsumedBy", "valueCode": "INV" } ] }, { "code": "OTH", "display": "other", "definition": "**Description:**The actual value is not a member of the set of permitted data values in the constrained value domain of a variable. (e.g., concept not provided by required code system).\r\n\r\n**Usage Notes**: This flavor and its specializations are most commonly used with the CD datatype and its flavors. However, it may apply to \\*any\\* datatype where the constraints of the type are tighter than can be conveyed. For example, a PQ that is for a true measured amount whose units are not supported in UCUM, a need to convey a REAL when the type has been constrained to INT, etc.\r\n\r\nWith coded datatypes, this null flavor may only be used if the vocabulary binding has a coding strength of CNE. By definition, all local codes and original text are part of the value set if the coding strength is CWE.", "property": [ { "code": "status", "valueCode": "active" }, { "code": "HL7usageNotes", "valueString": "This flavor and its specializations are most commonly used with the CD datatype and its flavors. However, it may apply to *any* datatype where the constraints of the type are tighter than can be conveyed. For example, a PQ that is for a true measured amount whose units are not supported in UCUM, a need to convey a REAL when the type has been constrained to INT, etc. With coded datatypes, this null flavor may only be used if the vocabulary binding has a coding strength of CNE. By definition, all local codes and original text are part of the value set if the coding strength is CWE." }, { "code": "internalId", "valueCode": "10616" }, { "code": "subsumedBy", "valueCode": "INV" } ] }, { "code": "UNC", "display": "un-encoded", "definition": "**Description:** The actual value has not yet been encoded within the approved value domain.\r\n\r\n**Example**: Original text or a local code has been specified but translation or encoding to the approved value set has not yet occurred due to limitations of the sending system. Original text has been captured for a PQ, but not attempt has been made to split the value and unit or to encode the unit in UCUM.\r\n\r\n**Usage Notes**: If it is known that it is not possible to encode the concept, OTH should be used instead. However, use of UNC does not necessarily guarantee the concept will be encodable, only that encoding has not been attempted.\r\n\r\nData type properties such as original text and translations may be present when this null flavor is included.", "property": [ { "code": "status", "valueCode": "active" }, { "code": "HL7usageNotes", "valueString": "If it is known that it is not possible to encode the concept, OTH should be used instead. However, use of UNC does not necessarily guarantee the concept will be encodable, only that encoding has not been attempted. Data type properties such as original text and translations may be present when this null flavor is included." }, { "code": "internalId", "valueCode": "22185" }, { "code": "subsumedBy", "valueCode": "INV" } ] }, { "code": "INV", "display": "invalid", "definition": "**Description:**The value as represented in the instance is not a member of the set of permitted data values in the constrained value domain of a variable.", "property": [ { "code": "status", "valueCode": "active" }, { "code": "internalId", "valueCode": "22656" }, { "code": "subsumedBy", "valueCode": "NI" } ] }, { "code": "MSK", "display": "masked", "definition": "There is information on this item available but it has not been provided by the sender due to security, privacy or other reasons. There may be an alternate mechanism for gaining access to this information.\r\n\r\nNote: using this null flavor does provide information that may be a breach of confidentiality, even though no detail data is provided. Its primary purpose is for those circumstances where it is necessary to inform the receiver that the information does exist without providing any detail.", "property": [ { "code": "status", "valueCode": "active" }, { "code": "internalId", "valueCode": "17932" }, { "code": "subsumedBy", "valueCode": "NI" } ] }, { "code": "NA", "display": "not applicable", "definition": "Known to have no proper value (e.g., last menstrual period for a male).", "property": [ { "code": "status", "valueCode": "active" }, { "code": "internalId", "valueCode": "10611" }, { "code": "subsumedBy", "valueCode": "NI" } ] }, { "code": "UNK", "display": "unknown", "definition": "**Description:**A proper value is applicable, but not known.\r\n\r\n**Usage Notes**: This means the actual value is not known. If the only thing that is unknown is how to properly express the value in the necessary constraints (value set, datatype, etc.), then the OTH or UNC flavor should be used. No properties should be included for a datatype with this property unless:\r\n\r\n1. Those properties themselves directly translate to a semantic of \"unknown\". (E.g. a local code sent as a translation that conveys 'unknown')\r\n2. Those properties further qualify the nature of what is unknown. (E.g. specifying a use code of \"H\" and a URL prefix of \"tel:\" to convey that it is the home phone number that is unknown.)", "property": [ { "code": "status", "valueCode": "active" }, { "code": "HL7usageNotes", "valueString": "This means the actual value is not known. If the only thing that is unknown is how to properly express the value in the necessary constraints (value set, datatype, etc.), then the OTH or UNC flavor should be used. No properties should be included for a datatype with this property unless: Those properties themselves directly translate to a semantic of \"unknown\". (E.g. a local code sent as a translation that conveys 'unknown') Those properties further qualify the nature of what is unknown. (E.g. specifying a use code of \"H\" and a URL prefix of \"tel:\" to convey that it is the home phone number that is unknown.)" }, { "code": "internalId", "valueCode": "10612" }, { "code": "subsumedBy", "valueCode": "NI" } ] }, { "code": "NINF", "display": "negative infinity", "definition": "Negative infinity of numbers.", "property": [ { "code": "status", "valueCode": "active" }, { "code": "internalId", "valueCode": "10618" }, { "code": "subsumedBy", "valueCode": "OTH" } ] }, { "code": "PINF", "display": "positive infinity", "definition": "Positive infinity of numbers.", "property": [ { "code": "status", "valueCode": "active" }, { "code": "internalId", "valueCode": "10617" }, { "code": "subsumedBy", "valueCode": "OTH" } ] }, { "code": "ASKU", "display": "asked but unknown", "definition": "Information was sought but not found (e.g., patient was asked but didn't know)", "property": [ { "code": "status", "valueCode": "active" }, { "code": "internalId", "valueCode": "10614" }, { "code": "subsumedBy", "valueCode": "UNK" } ] }, { "code": "NASK", "display": "not asked", "definition": "This information has not been sought (e.g., patient was not asked)", "property": [ { "code": "status", "valueCode": "active" }, { "code": "internalId", "valueCode": "10613" }, { "code": "subsumedBy", "valueCode": "UNK" } ] }, { "code": "NAVU", "display": "Not available", "definition": "Information is not available at this time (with no expectation regarding whether it will or will not be available in the future).", "property": [ { "code": "status", "valueCode": "active" }, { "code": "internalId", "valueCode": "23731" }, { "code": "subsumedBy", "valueCode": "UNK" } ] }, { "code": "QS", "display": "Sufficient Quantity", "definition": "**Description:**The specific quantity is not known, but is known to be non-zero and is not specified because it makes up the bulk of the material. e.g. 'Add 10mg of ingredient X, 50mg of ingredient Y, and sufficient quantity of water to 100mL.' The null flavor would be used to express the quantity of water.", "property": [ { "code": "status", "valueCode": "active" }, { "code": "internalId", "valueCode": "21436" }, { "code": "subsumedBy", "valueCode": "UNK" } ] }, { "code": "TRC", "display": "trace", "definition": "The content is greater than zero, but too small to be quantified.", "property": [ { "code": "status", "valueCode": "active" }, { "code": "internalId", "valueCode": "21386" }, { "code": "subsumedBy", "valueCode": "UNK" } ] } ] }